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Abstract
Self-transmissible plasmids are key vectors in the transfer of resistance, catabolic,
and other genes among bacteria native to environments such as streams and wetlands.
The evolution of antibiotic resistance in particular is known to be powerfully affected by
conjugative plasmid transfer due to the ease in which some plasmids can be horizontally
transferred into a broad range of host bacteria and their ability to exchange mobile
genetic elements that often contain antibiotic resistance genes.
In this study, we captured tetracycline resistance plasmids from stream sediments
impacted by agricultural runoff. We selected for resistance plasmids using tetracycline,
an antibiotic commonly used in agricultural operations, due to the numerous neighboring
cattle pastures and poultry farms. We hypothesized that stream sediment is a “hot spot”
for horizontal gene transfer due to the use of antibiotics in agricultural operations
combined with runoff into streams. Selective pressures exerted on gut and fecal bacteria
of farm animals may select for antibiotic resistance genes that can be horizontally
transferred to native stream sediment bacteria when runoff events occur.
We characterized four transmissible, tetracycline resistance plasmids: the 71 kb
IncP-1β plasmid pEG1-06, the 121 kb IncA/C2 plasmid pCCRT11-6, and the 59 kb IncP9 plasmids pCCP1 and pCCP2. We built upon and improved the methods developed for
the preparation of plasmid DNA for sequencing using 2nd and 3rd generation DNA
sequencers, hybrid genome assembly, annotation, and analysis. We demonstrated this
process by assembling the four plasmid genomes into single, circular contiguous
sequences and compared them to the closest related plasmids allowing us to classify their
vi

respective incompatibility groups, reveal the essential backbone and accessory
genes present on the plasmid genomes including antibiotic resistance genes, and
determine their similarity to the closest related known, existing plasmids.

vii

1
General Introduction
Plasmids. Plasmids are circular elements of double-stranded DNA found in
bacteria, archaea, and some eukaryotes that are normally replicated independently of
chromosomal DNA. Many – those known as self-transmissible or as mobilizable
plasmids – can be horizontally transferred between mature bacteria by conjugation.
Genes commonly found in plasmids often encode traits that help a bacterium adapt and
survive in its environment, such as antibiotic resistance genes, virulence genes, and other
unique genes. Due to the mosaic nature of plasmids they can also serve as vehicles for
other mobile and mobilizable genetic elements such as integrons and transposons, which
adds yet another level of potential recombination and mobility.
A self-transmissible or conjugative plasmid is defined as a plasmid that contains
genes for all four components of a membrane mating pair formation complex: (1) an
origin of replication, (2) a relaxase, (3) a type IV coupling protein, and (4) a type IV
secretion system. A mobilizable plasmid is defined as a one that only contains genes for
three of four components of a conjugative complex and lacks the genes for a type IV
secretion mating channel which is required for the conjugation process. Mobilizable
plasmids differ from self-transmissible plasmids in that they rely upon the presence of a
mating channel from another genetic element (e.g. a self-transmissible plasmid) present
in the cell in order for horizontal gene transfer (HGT) to occur (Smillie et al., 2010).
Plasmids are typically classified either by their incompatibility group or by
mobility typing (MOB). Plasmid incompatibility is defined as the failure of two coresident plasmids to be stably inherited together in the absence of external selection
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(Novick et al., 1976). If two plasmids exist in the same cell and are of the same
incompatibility group, only one will be replicated and vertically passed down to its
progeny. Plasmid typing based on incompatibility groups has been the gold standard for
plasmid classification for many years; however due to the mosaic nature of plasmid
genomes (i.e. plasmids are dynamic and plastic in their ability to gain or lose genes
through horizontal gene transfer), the classification of plasmids using incompatibility has
not always reflected their true evolutionary relationships (Alvarado et al. 2012). Highly
similar plasmids can be compatible while largely non-homologous plasmids can be
incompatible (Alvarado et al., 2012). A newer method to classify plasmids is based on
Degenerate Primer Mobility Typing (DPMT) (Alvarado et al., 2012; Garcillan-Barcia et
al., 2015). DPMT is a PCR-based typing strategy that aims to characterize plasmids
based on evolutionary relationships among relaxase genes (MOB genes), because these
are the only genes that are common to all transmissible and mobilizable plasmids
(Garcillin-Barcia et al., 2015).
IncP plasmids. Plasmids belonging to the IncP incompatibility group are a wellcharacterized group of plasmids due to their high prevalence, their clinical relevance due
to their often containing multiple antibiotic resistance genes, and their broad host range.
IncP plasmids are described as “promiscuous” plasmids due to their ability to replicate
and be stably maintained in almost all Gram-negative bacteria. They are often found in
the Enterobacteriaceae in genera such as Salmonella, Escherichia, and Klebsiella, as well
as Pseudomonas (a non-Enterobacteriaceae in which they are designated IncP-1)
(Adamczyk and Jagura-Burdzy, 2003). IncP plasmids often contain genes that encode
catabolic functions such as the degradation and utilization of chemical compounds such
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as xylene or toluene (Dennis, 2005). They frequently contain a variety of antibiotic
resistance genes conferring resistance to (for example) tetracyclines, sulfonamides,
extended spectrum β-lactams, and aminoglycosides (Rozwandowicz et al., 2018).
IncA/C plasmids. IncA/C plasmids are a group of low-copy number, selftransmissible plasmids that range in size from 40-230 kb, although smaller conjugative
variants with sizes 18-25 kb have been reported (Rozwandowicz et al., 2018). They have
a broad host range and are typically found in members of the Beta-, Gamma-, and
Deltaproteobacteria, including species such as Escherichia coli, Klebsiella pneumoniae,
Salmonella enterica, Vibrio cholerae, and Aeromonas hydrophila (Harmer and Hall,
2015). These plasmids often carry genes of clinical significance such as antibiotic
resistance genes conferring resistance to carbapenems, third-generation cephalosporins,
sulfonamides, tetracyclines, and extended-spectrum beta-lactam antibiotics which can
make treatement of a drug-resistant infection difficult if the causative agent has an
IncA/C plasmid (Carattoli et al., 2012). These resistance genes are often located on
antibiotic resistance islands (ARI-A or ARI-B) which are associated with the global
dissemination of extended-spectrum β-lactamase genes via IncA/C (Rozwandowicz et al.,
2018). The IncA/C plasmids are divided into two variants, A/C1, which is typified by the
IncA reference plasmid pRA1, and A/C2 a variant that differs by 26 single nucleotide
polymorphisms in the repA gene (plasmid replication protein A) (Rozwandoicz et al.,
2018). IncA/C2 plasmids are further divided into two groups, type 1 and type 2, and these
differ based on the amino acid length of the rhs gene (as a result of the accumulation of
insertions and deletions) as well as the presence of ARI-A and ARI-B (ARI-A is only
found in type 1, ARI-B found in both types) (Harmer and Hall, 2015).
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Antibiotic resistance. Humans are currently participating in an antibiotic and
antibiotic resistance arms race with bacteria, where bacteria develop resistance to the
antibiotics used by humans to rid them of pathogenic bacteria causing disease. The rate of
bacterial evolution is clearly outpacing the rate that humans are able to discover new and
effective antibiotics. The highly mutable nature of bacterial genomes is a major
contributor to the evolution of bacteria, allowing them to adapt to their environment and
persist under unfavorable conditions (Davies and Davies, 2010).
The observed increase in antibiotic resistance is likely not only due to use, the
misuse, and overuse of antibiotics as a treatment for human infection, but also to the
overuse of antibiotics in agriculture (Wegener, 2003). The US Food and Drug
Administration (FDA) Center for Veterinary Medicine reported that from 2009 to 2016
domestic sales and distribution of antimicrobials approved for use in food-producing
animals increased by 11% (Center for Vet Medicine at FDA, 2017). In 2016, 13,983,016
kg (15,413.6 tons) of antimicrobials were sold while 42% of those sold were tetracyclines
(Center for Vet Medicine at FDA, 2017). Sixty-nine percent of the antimicrobials sold in
the US were approved by the FDA and labeled for use in both therapeutic (treatment of a
bacterial infection) and non-therapeutic or production applications (increased weight
gain) while 31% were labeled solely for therapeutic applications (Center for Vet
Medicine at FDA, 2017).
The use of antibiotics and antimicrobials in animal husbandry over the past 30
years has actively selected for bacteria that possess genes conferring antibiotic resistance
(Cantas et al., 2013). These resistant populations of bacteria are present in feces and
eventually may enter adjacent water sources via runoff from neighboring agricultural
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areas. Bacteria introduced into a system via runoff are able to exchange mobile genetic
elements with native bacteria using horizontal gene transfer (HGT) mechanisms (Fry and
Day, 1990). Streams and stream sediment harbor large, diverse populations of native
bacteria. If in close proximity to a farm, these populations of native bacteria that live in
the stream water column or sediment are subject to periodic or continuous contact with
fecal bacteria via direct deposition or runoff from applied fertilizer (Herrick et al., 2014).
Such contact could lead to the transmission of antibiotic resistance genes between nonpathogenic native bacteria and pathogenic (and opportunistic pathogenic) fecal bacteria.
In Virginia, the Department of Environmental Quality (DEQ) is tasked with
monitoring and reporting the quality of the various bodies of water within the state. They
determine that a waterbody is “impaired” when it contains more of a pollutant than is
allowed by water quality standards. For all of the rivers and streams in the state that were
assessed by the DEQ, 70% were designated as “impaired” due to high levels of fecal
bacteria. In the Potomac-Shenandoah river basin, where this study was conducted, 79%
of the rivers designated as “impaired” were due to the presence of fecal bacteria (DEQ,
2016).
Horizontal gene transfer. HGT is perhaps the primary cause of the rapid spread
of antibiotic resistance (Revilla et al., 2008). Bacteria use HGT, the transfer of DNA
between mature cells, and vertical transfer of DNA to progeny, to adapt to stressful
conditions and thrive in new environments (Smillie et al., 2010). HGT can occur between
both closely and distantly related species alike and can potentially occur between nonpathogenic and pathogenic bacteria (Shoemaker et al., 2001). Exchange of antibiotic
resistance genes from a non-pathogenic species to pathogenic species is one of the most
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concerning potential outcomes of HGT. There are three classical mechanisms of
horizontal gene transfer: transduction, transformation, and conjugation.
Transduction is the transfer of new genetic material into a bacterium by a
bacteriophage (a virus that infects bacteria) that has replicated its genome within a donor
bacterium. It can either transfer packaged, random DNA fragments made using the host’s
replication machinery or the DNA adjacent to the phage attachment site (Ochman et al.,
2000). Fairly large amounts of DNA can be transferred in a single event and is only
limited by the size of the phage capsid (Ochman et al., 2000). This form of HGT is less
likely to occur than transformation or conjugation due to the fact that phages have a
limited host range largely dependent upon the surface proteins found on their host that aid
in attachment (Smillie et al., 2010). Transduction is unique in that it does not require
physical contact between the donor cell and the recipient cell. One of the more wellknown examples of transduction is the acquisition of the genes that code for Shiga toxin
production in pathogenic Escherichia coli O157:H7. This strain received these genes via
a bacteriophage early in its evolutionary history and this transduction event caused a
major change in its genome and its ability to cause disease in humans (Wick et al., 2005).
The second mechanism of HGT is transformation, which is the uptake and
incorporation of naked DNA from the environment into bacterial cells. Both
chromosomal and extrachromosomal (plasmid) DNA can be transformed into bacteria
and does not require a living donor. Most naked DNA is a result of cell lysis and can
originate in cells that are not closely related or proximal to the recipient (Lorenz and
Wackernagel, 1994). Not all bacteria are competent, or able to take up foreign DNA.
Competency can either occur naturally or can be induced by a variety of artificial
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treatments, such as heat-shock, CaCl2, and electro-shock or electroporation (Chen and
Dubnau, 2004). Induced competency increases cellular membrane fluidity by creating
small pores in the membrane to allow for DNA (typically plasmids) to traverse the
membrane.
The third route for HGT is conjugation. Physical contact between two bacterial
cells is necessary to initiate gene transfer between donor and recipient cells (Gotz and
Smalla, 1997). Typically, the form of DNA being exchanged during conjugation is a selftransmissible or mobilizable plasmid. Successful conjugation depends on the genetic
information and is encoded by the plasmid itself. There are several genes involved in the
conjugation mechanism which function to form the conjugative bridge - the pilus between the donor and recipient. This mechanism is required to transfer and copy a
plasmid into the recipient but may also be a conjugative transposon (Ochman et al.,
2000).
HGT and antibiotic resistance. The ability of bacteria to transfer and rearrange
genetic content to gain new traits has been clearly demonstrated in terms of antibiotic
resistance (Smillie et al., 2010). One recent instance of horizontal gene transfer of
antibiotic resistance genes is the spread of colistin resistance among bacteria such as E.
coli and Klebsiella pneumoniae (Liu et al., 2015). Colistin belongs to the family of
polymyxin antibiotics and has a broad spectrum of activity against many Gram-negative
bacteria including most species of Enterobacteriaceae (Li et al., 2006). Doctors rely on
colistin as a last resort antibiotic to treat carbapenem-resistant bacterial infections.
Colistin has been used in sub-therapeutic amounts for animal growth promotion in some
agricultural operations in China (Doyle et al., 2013).
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A recently discovered plasmid-mediated gene that confers resistance to colistin,
mcr-1, was found in high abundance among E. coli isolates sampled from raw meat,
animals, and infected patients in central and eastern China (Liu et al., 2015). The authors
observed mcr-1 carriage in 15% of raw meat samples, 21% of animals, and 1% of
patients across 13 different provinces in China. The most alarming aspect of this study
was the apparent ease in which a plasmid containing the mcr-1 gene was transferred
among differing pathogenic bacterial species such as E. coli, Pseudomonas aeruginosa,
and K. pnemoniae. The plasmid, pHNSHP45, can not only be transferred at a high rate, it
has also been shown to be stable in these bacteria, even without the selective pressure of
antibiotics (Liu et al., 2015). This is harrowing news, as plasmid-borne colistin-resistance
may inevitably spread among pathogenic bacteria which could potentially infect human
populations.
Second generation DNA sequencing. The 2005 release of 454 Life Sciences’
DNA sequencer, the 454 GS20, marked the advent of 2nd generation DNA sequencing
(Marguilies et al., 2005). The GS20 was the first commercially-available device that had
the capability of massively parallel DNA sequencing. The device delivered up to 25
megabases (1 megabase = 1 million bases) per sequencing run (Margulies et al., 2005),
which was much higher DNA sequence throughput than first generation Sanger
sequencing technologies.
Second generation sequencers differ from first generation sequencers in that they
allow for the multiplexing of sequencing reactions. This means that the device can
sequence multiple strands of DNA in parallel, thus allowing second generation
sequencers to have much greater scalability (Shendure et al., 2017). This key distinction
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drove the cost of sequencing down immensely, as data could be generated much faster for
a larger number of samples. In 2004, the cost of sequencing 1 megabase was
approximately $1000 and in 2008, when many sequencing centers adopted and began
using 2nd gen sequencers, the cost dropped to under $10 per megabase. In 2017, due to
further advancements in sequencing technologies, the cost has plummeted even further to
$0.012 per megabase (Wetterstrand, 2017).
The 454 Life Sciences lineup of sequencers and other 2nd generation sequencers
from companies such as Solexa/Illumina and Ion Torrent, all operate using “sequencing
by synthesis” approaches (SBS) (Morey et al., 2013). First, DNA is clonally amplified by
polymerase chain reaction (PCR), meaning that a DNA fragment is amplified into many
identical copies which are then denatured into single-stranded DNA fragments. Second,
the single-stranded, amplified fragments are spatially separated and immobilized on a
surface, usually on a flowcell (Illumina) or a microchip (Ion Torrent) (Shendure et al.,
2017). Finally, single stranded DNA templates are subject to polymerization of their
complementary strands, one nucleotide at a time, to allow for the detection of each
nucleotide. Detection methods differ between the various technologies, but typically
when a nucleotide is added to the complementary strand, a byproduct is released, such as
hydrogen ions (H+) or light (Morey et al., 2013).
Illumina sequencing by synthesis. Illumina is aptly named for the light-based
sequencing methods that are employed in their sequencers. During a sequencing run,
fluorescently-labelled “reversible-terminator” deoxynucleotides (dNTP’s) are used for
polymerization of the complementary DNA strand (Turcatti et al., 2008). Between each
sequential nucleotide addition, lasers are used to excite the fluorophore that is attached to
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the dNTP, and the signal is recorded using a camera. This signal is used to derive the
nucleotide sequence that was incorporated into each individual DNA strand (Shendure et
al., 2017).
Second generation sequencers rely upon PCR for various processes throughout
their respective sequencing workflows, and while PCR enables the generation of massive
amounts of sequence data, it has its drawbacks. Clonal amplification of DNA can lead to
amplification biases resulting in uneven uniformity of coverage and potential sequencing
artifacts due to polymerase errors (Acinas et al., 2005). To minimize the effects of these
biases, clonal amplification reactions are performed with a reduced number of cycles
(usually under 15 cycles) to limit polymerase errors (Asan et al., 2011). The
amplification of DNA also results in a loss of information in that post-transcriptional
modifications (e.g. methylation) are lost post-amplification. The loss of nucleotide
modifications is a hindrance if the investigator is specifically interested in modifications;
however it is by and large an advantage due to the increase in basecalling accuracy. The
increase in basecalling accuracy is due to the sequencer not having to differentiate
between 5-mC and non-methylated cytosine signals.
Despite the low cost per base, high accuracy, and high throughput of second
generation sequencers, the main disadvantage of these sequencers for the purposes of
genome assembly, is the short read length of the data produced, which range anywhere
from 35 - 500 bp (typically on the shorter side around 75-150 bp). Short reads, regardless
of how high their accuracy is, can make genome assembly a challenge, especially when
assembling a genome de novo. Genomes that contain long repetitive elements prevent the
resolution of a genome and are especially difficult to assemble when the repetitive
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element is longer than the length of the sequence reads and in the case of bacterial
genomes, 2nd generation sequencers oftentimes cannot provide complete genome
sequences (Pallen and Loman, 2015).
Third generation DNA sequencing. Third generation sequencers are distinct
from 2nd generation sequencers in that they sequence native DNA molecules directly and
not from a synthesized template. Oxford Nanopore Technologies (ONT) and Pacific
Biosciences (PacBio) Single Molecule, Real-Time (SMRT) sequencing technologies
dominate the 3rd generation sequencing market as they produce sequence reads directly
and at lengths much higher than 2nd generation sequencers. PacBio and ONT users report
reads typically over 10 kb and up to 100 kb (Shendure et al., 2017). In theory, nanopore
sequencers have no limits to their read lengths and through the use of careful, high
molecular weight DNA extractions and library preparation protocols users have obtained
single “ultra-long” reads up 882 kb in length (Jain et al., 2018). With increasingly longer
sequence read lengths becoming more readily available and accessible, scientists are able
to apply them to the long-standing problems associated with short read sequence data.
Bacterial genomes have been assembled using long reads such as the 4.6 Mb E. coli K-12
MG1655 genome (Loman et al., 2015), the 1 Mb Rickettsia typhi genome (Elliot et al.,
2018), and the 5.7 Mb Klebsiella pneumoniae genome (Wick et al., 2017). Additionally,
3rd generation sequencers have allowed for the assembly of large and complex eukaryotic
genomes such as Arabadopsis thaliana (135 Mb genome) and human (3.1 Gb genome)
and result in assemblies that are much more contiguous and structurally accurate than
those possible with short read data alone (Michael et al., 2018; Jain et al. 2018).
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Nanopore sequencing. Nanopore sequencers measure picoampere (pA) level
changes in ionic current as single stranded DNA (ssDNA) molecules pass through a
biological nanopore. Within the flowcells of all ONT sequencers are arrays of biological
(i.e. non-synthetic) nanopores. These pores have a 1-2 µm opening that allows ssDNA
molecules to pass through at a speed of 450 bases per second, and whose speed is guided
by a motor protein that rests on top of the nanopore (Oxford Nanopore, 2016). The speed
at which bases are sequenced combined with the multiplexing of sequencing across an
array of 2048 nanopores controlled in groups of 512 channels allows for the routine
generation of 3-5 Gb (some users report up to 18 Gb) of data per flowcell (Leggett and
Clark, 2017).
One of the main advantages of nanopore sequencing is that does not require PCR
amplification prior to or during sequencing, thus eliminating a potential source of bias in
the sequence data. Another main advantage to this technology is that since it allows for
the detection of nucleotide sequence directly from native molecules, it can also detect and
discriminate base-modifications, such as methylated residues (Jain et al., 2016) and for
the first time in history, allows for the sequencing of RNA molecules directly without the
requirement for conversion to cDNA (Garalde et al., 2018).
Nanopore sequencing does have disadvantages, some of which will be discussed
in detail in the first chapter. One of the main drawbacks is that since ONT sequencers do
not require PCR prior to sequencing (although ONT does have library preparation kits for
low-quantity samples that involve amplification), the required minimum quantity of
starting DNA is high compared to 2nd generation sequencers, ranging from 400 ng to 1 µg
depending on the library preparation kit that is used (compare to the range of 1 ng to 500
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ng required for Illumina sequencing). Another disadvantage to ONT sequencing is that
because the sequencer is essentially threading DNA through a biological protein, the
nanopores are sensitive to contaminants in DNA samples and various other factors such
as exposure to air or dramatic temperature changes. Therefore, ONT sequencers require
that DNA samples are extremely pure, non-degraded, and free of contaminants such as
phenol, ethanol, salts, EDTA, etc. that may degrade or denature the nanopores, which
leads to lower quality data and lower throughput.
The biggest drawback to ONT sequencing is the accuracy of the reads, which is
currently estimated to be ~86% for the median read identity (weighted by read length)
with an average distribution ranging from 65-95% read identity for 1-dimensional (1D)
reads (Wick et al., 2018). This accuracy rate deters many researchers from using the
technology, especially if their project requires a high accuracy rate of sequence data, but
the data is useable for many other purposes, such as real-time detection of pathogenic
bacteria or viruses (e.g. Ebola virus), hybrid short and long read de novo genome
assembly, and detection of structural variants in cancer cell lines (Quick et al., 2016;
Wick et al., 2017; Norris et al., 2016).
Sequencing on Illumina and ONT platforms for hybrid assembly. While data
from either a 2nd or a 3rd generation sequencer can be sufficient for generating a de novo
draft genome assembly, both approaches can be used in conjunction to produce genome
assemblies that are highly accurate in structure and sequence. Such a “hybrid” approach
takes advantage of the high accuracy rate of the short reads and the read lengths of the
long reads. There are two main approaches to a hybrid assembly, the first of which is to
assemble using the long reads first and perform error correction using the short reads.
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Tools such as Miniasm (an overlap layout consensus-based assembler) and Pilon (which
polishes draft genome assemblies by using high accuracy short reads) have been
developed for this purpose (Li, 2016; Walker et al., 2014). The second approach is to
assemble the short reads first and scaffold the contigs using the long reads. Tools such as
Unicycler have been developed for this purpose, specifically for de novo assembly of
bacterial genomes and plasmids (Wick et al., 2017).
In this study, we build upon and improve the methods developed by Libuit (2016)
for the preparation of plasmid DNA for sequencing, plasmid genome assembly,
annotation and analysis of large, antibiotic resistance plasmids using 2nd and 3rd
generation DNA sequencers. We demonstrate this process by sequencing four
tetracycline resistance-encoding plasmids that vary in size, incompatibility group, and
copy-number that were captured without cultivation of the host(s) from streams located in
the Shenandoah Valley. The genomes of self-transmissible tetR plasmids pEG1-06,
pCCRT11-6, pCCP1, and pCCP2 were sequenced, assembled de novo, annotated, and
compared to the closest related plasmids allowing us to classify their respective
incompatibility groups, reveal the various genes present on the plasmids, and determine
their similarity to the closest related plasmids.
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Chapter 1
A method for preparing isolated plasmid DNA for sequencing on Illumina and
Oxford Nanopore Technologies sequencers
Introduction
Whole genome sequence (WGS) data of bacterial isolates contain not only
chromosomal sequence content but will additionally contain plasmid sequence if the
isolate harbors one or more plasmids that are sequenced alongside the chromosomal
DNA. Resolving plasmid genomes from WGS data poses many challenges, because
plasmids commonly share repetitive sequences with the chromosome, making plasmid
genome assembly difficult, especially when short sequence reads are used (ArredondoAlonso et al., 2017). Long reads that are capable of spanning beyond these shared
repetitive regions can be assembled in a “hybrid” manner with the short reads to solve
these assembly issues (Wick et al., 2017); however there is the possibility that in the
process of preparing libraries and sequencing them, plasmids can be missed or excluded
altogether and this may occur for a number of reasons. One could be due to sheer
probability, in the case that a plasmid is low-copy number and each cell contains one
plasmid copy per cell. The sheer size and abundance of the chromosome may outweigh a
small plasmid and it could be missed. Another possibility is that a plasmid’s supercoiling
states may prevent it from being incorporated into sequencing libraries, due to no free
ends being available for the ligation of required sequencing adapters. These potential
issues must be considered when preparing isolated plasmid DNA for library preparation
and sequencing.
There is a gap in the literature for detailed methods describing how to extract and
prepare pDNA for library preparation and sequencing on 2nd and 3rd generation DNA
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sequencers. Some recent publications describe the use of the 3rd generation sequencer, the
Oxford Nanopore MinION, for obtaining long sequence reads for isolated, large plasmids
(Szabó et al., 2016; Li et al., 2018); however the methods described are very brief and do
not take into account the unique characteristics of plasmids that could potentially prevent
them from being sequenced properly. Much of the literature on preparing isolated pDNA
for sequencing is geared towards preparing plasmids, cosmids, and bacterial artificial
chromosomes (BACs) for 1st generation Sanger sequencing, and oftentimes these
methods rely upon the use of a commercial extraction kit. Williams et al. describe their
method for “facile recovery of individual high molecular weight, low-copy plasmids for
sequencing,” however the protocol can take 2-3 days to perform and involves laborintensive protocols such as extracting bands from agarose gels as a method to separate
pDNA from chromosomal DNA (Williams et al., 2006).
We present here a simple, rapid, and efficient method for extracting and preparing
pure plasmid DNA in sufficient quantity and quality for sequencing library preparation
on two sequencing platforms. Our large plasmid extraction technique is alkaline lysis
based, does not require the use of a potentially expensive commercial extraction kit, and
can be performed in approximately 2 hours using reagents and equipment that are
common to molecular biology-equipped laboratories. We discuss the challenges faced
when working with plasmid DNA, provide the specific techniques used to overcome
these challenges and show the results of multiplexed Illumina MiniSeq and Oxford
Nanopore MinION sequencing runs and the data produced as a result of our efforts. We
hope that these techniques will prove useful to those interested in sequencing single, large
plasmids (up to potentially 300kb or larger) on either Illumina or Oxford Nanopore

17
Technologies (ONT) sequencers for the purpose of plasmid genome assembly and
characterization.
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Methods
Plasmid extraction. Tetracycline resistant cells were cultured at 37 ºC overnight
in 10 mL of TSB amended with tetracycline (12.5 μg/mL) (Figure 1). A 1.5 mL aliquot
of turbid broth was centrifuged at 10,000 x g for 5 min and the supernatant was removed
from the cell pellet by aspiration. The cell pellet was resuspended using 100 μL of an
alkaline resuspension buffer (10 mM EDTA; 50 mM dextrose; 10 mM Tris-Cl, pH 8.0).
One hundred microliters of freshly prepared 0.2 M NaOH/1% SDS were added to lyse
the cells. Cells and SDS solution were mixed by inversion 5X and allowed to set at room
temperature for 5 min. One hundred and fifty microliters of ammonium acetate (7.5 M)
were added to reduce pH, immediately followed by the addition of 150 μL of chloroform,
to denature proteins. The tube was gently inverted 5X before placing it on ice for 10 min
to allow the plasmid DNA to dissolve. The mixture was centrifuged at 16,000 x g for 10
min and the supernatant was removed by aspiration and added to 200 μL PEG/NaCl
solution (30% polyethylene glycol 8000, 1.5 M NaCl) to aid in the separation of plasmid
from chromosomal DNA. This was chilled on ice for 15 min and centrifuged at 16,000 x
g for 10 min. The supernatant was removed by aspiration. One milliliter of freshly
prepared, chilled 70% ethanol was added to the tube and centrifuged at 10,000 x g for 5
min. The supernatant was removed and the tubes were allowed to air dry for no longer
than 10 min. After drying, the remaining plasmid DNA pellet was reconstituted in 50100 μL of MilliQ ddH2O (MQ water). Plasmid DNA was allowed to dissolve for >24 hrs
at 4°C and then stored for long-term at -20°C. RNAse A (Amresco, Solon, OH) was
added to a concentration of 10 μg/mL to degrade RNA.

19

Figure 1. Plasmid extraction workflow.

Scaled-up plasmid extraction. To obtain larger quantities of DNA that are
required for MinION sequencing (1-1.5 μg total DNA), the plasmid isolation protocol
was scaled up using larger volumes of E. coli cultures (Libuit, 2016). Using a 50 ml
Falcon® tube, EC100 cells harboring captured tetR plasmids were grown in 30 mL of
trypticase soy broth with shaking at 37º C overnight (180 RPM). Cells were harvested by
centrifugation at 10,000 x g for 5 min and resuspended in 2 mL of resuspension buffer
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(10 mM EDTA; 50 mM dextrose; 10 mM Tris-Cl, pH 8.0). Four milliliters of 0.2 M
NaOH/1% SDS were added and the mixture kept at room temperature for 5 min. Three
milliliters of ammonium acetate (7.5 M) and 3 mL of chloroform were added and the tube
was gently swirled 5X before placing it on ice for 10 min. The tube was then centrifuged
at 16,000 x g for 10 min. The supernatant containing plasmid DNA was added to 4 mL
PEG/NaCl solution and chilled on ice for 15 min. Plasmid DNA was pelleted by
centrifugation at 16,000 x g and resuspended in 1 mL of MQ water. DNA samples were
kept at 4º C for >24 hrs to allow plasmid DNA to dissolve and then the samples were
stored at -20°C.
The presence of plasmid DNA (pDNA) was confirmed by agarose gel
electrophoresis. A 1% agarose gel was cast by boiling 0.6 g of agarose in 60 mL of 1X
TAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0). Eight microliters of plasmid
DNA were mixed with 2 μL of 5X loading dye and the mixture run on the gel at 3.5V/cm
for 90 min. In ladder lanes, 2 μL of 5X loading dye were mixed with 1 μL of
lambda/HindIII digest and 7 μL of 1X TAE. Gels were stained in a 3X GelRed Nucleic
Acid Gel Stain (Biotium, Hayward, CA) bath for at least 20 min and rinsed in DI water
for 5 min. Gel images were taken with a Bio-Rad ChemiDoc XRS+ System and analyzed
using Image Lab software (Bio-Rad, Hercules, CA).
Pre-library preparation plasmid DNA treatment. To remove contaminating
chromosomal DNA, plasmid DNA samples were treated with Plasmid-Safe™ ATPdependent DNase (Epicentre Technologies, Madison, WI). Forty-two microliters of
plasmid DNA were mixed with 5 μL of Plasmid-Safe™ 10X Reaction buffer (330 mM
Tris-acetate (pH 7.5), 660 mM potassium acetate, 100 mM magnesium acetate, and 5
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mM DTT), 2 μL of 25 mM ATP, and 1 μL of Plasmid-Safe™ DNase. For treating
volumes of plasmid DNA greater than 42 μL, the volumes of the components listed
above were increased proportionately. The tubes were incubated at 37°C for 30 min and
the enzyme was inactivated by incubation at 70°C for 30 min.
Restriction enzyme digestion of plasmid DNA for sequencing. To linearize the
plasmid DNA samples for Illumina MiniSeq sequencing, the restriction enzyme EcoRI
(New England BioLabs, Ipswich, MA [NEB]), was used. Sixteen and a half microliters of
plasmid DNA were mixed with 2 μL of NEBuffer™ EcoRI (NEB) and 0.5 μL of EcoRI.
The tubes were incubated at 37°C for 30 min and the enzyme was inactivated by
incubation at 70°C for 30 min. For treating volumes of plasmid DNA greater than 16.5
μL, the volumes of the components listed above were increased, proportionately.
To linearize the plasmid DNA samples for Oxford Nanopore MinION
sequencing, the restriction enzyme Sau3AI (NEB) was used to partially digest the DNA.
One-hundred and seventy-nine microliters of plasmid DNA were mixed with 20 μL of
NEBuffer 1.1 (NEB) and 0.2 μL of Sau3AI (5000 U/μL) (NEB). Immediately after
adding the enzyme, the tubes were flicked to homogenize the solution and briefly
centrifuged. Directly following centrifugation, the tubes were placed into a pre-warmed
70°C heating block for 30 min to inactivate the enzyme.
After Plasmid-Safe™ and restriction digestion (with either EcoRI or Sau3AI)
were performed, samples were purified and concentrated using 1X volume of Agencourt
AMPure XP Beads according to the manufacturer’s instructions (Beckman Coulter, Brea,
CA).
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Library preparation. Plasmid DNA purity was verified using a Synergy H1
Multi-Mode Reader (BioTek Instruments, Winooski, VT). DNA was quantified using a
QubitTM 2.0 fluorometer (Invitrogen, Carlsbad, CA) using either the Qubit dsDNA BR kit
(Broad Range; quantitation range = 2 – 1000 ng total DNA) or the Qubit dsDNA HS kit
(High Sensitivity; quantitation range = 0.2 - 100 ng total DNA) according to the
manufacturer’s instructions.
Library preparation for Illumina MiniSeq sequencing. Sixteen MiniSeq
sequencing libraries were prepared (only 4 of 16 were plasmid samples, other samples
were for unrelated projects) using 1 ng of digested (RNAse A, PS, and EcoRI) plasmid
DNA (5 μL @ 0.2 ng/μL) per sample. The Nextera XT DNA Library Preparation Kit
(Illumina, San Diego, CA) and the Nextera XT Index Kit (Illumina) were used to prepare
and dual-index each of the libraries, respectively.
Five microliters of each digested pDNA sample were added to 10 μL of Tagment
DNA buffer (TD, Illumina) in a hard-shell skirted 96-well PCR plate (Bio-Rad, Hercules,
CA). Five microliters of Amplicon Tagment Mix (ATM, Illumina) were added to each
well and mixed by pipetting up and down briefly. The 96-well plate was centrifuged at
280 x g for 1 min at room temperature. The 96-well plate was placed in a thermocycler
and incubated at 55°C for 5 min and cooled to 10°C. Immediately following, 5 μL of
Neutralize Tagment buffer (NT, Illumina) were added to stop the transposome reaction.
The 96-well plate was centrifuged at 280 x g for 1 min and incubated at room
temperature for 5 min.
Tubes containing Nextera XT dual index primers were arranged in a TruSeq
Index Plate Fixture (Illumina) to assist with adding unique combinations of indices to the
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samples. Across the top row of the plate fixture, tubes of the following i7 indices were
arranged from left to right: N701 (5’-TCGCCTTA-3’), N702 (5’-CTAGTACG-3’), N703
(5’-TTCTGCCT -3’), N704 (5’-GCTCAGGA -3’). In the first column of the plate
fixture, tubes of the following i5 indices were arranged from top to bottom: N517 (5’GCGTAAGA-3’), N502 (5’-CTCTCTAT -3’), N503 (5’-TATCCTCT-3’), N504 (5’AGAGTAGA -3’). A multi-channel pipette was used to transfer 5 μL of the i7 indices to
each of the rows of wells containing samples. Five microliters of each of the i5 indices
were transferred to each of the columns of wells containing samples. Fifteen microliters
of Nextera PCR Master Mix (NPM, Illumina) were added to each well containing a
sample and mixed by pipetting. The 96-well plate was centrifuged at 280 x g for 1 min.
The indices were ligated to the tagmented DNA fragments and amplified using the
following limited-cycle PCR program: 72°C for 3 min, 95°C for 30 s, 12 cycles of [95°C
for 10 s, 55°C for 30 s, 72°C for 30 s], 72°C for 5 min, and hold at 10°C.
Following amplification/ligation, the libraries were purified using Agencourt
AMPure XP magnetic beads (Beckman-Coulter). The 96-well plate was centrifuged at
280 x g for 1 min. Fifty microliters from each sample were transferred to a 0.8 mL 96well midi plate (Fisher Scientific, Waltham, MA). Thirty microliters of AMPure XP
beads (0.6X volume) were added to each of the wells and the plate was placed in a plate
shaker for 2 min at 1800 RPM. The 96-well plate was incubated at room temperature for
5 min and then placed on a magnetic stand for 2 min. Once the beads pelleted and the
samples cleared in color, the supernatant was removed by aspiration and discarded. The
pellets were washed twice by adding 200 μL of freshly prepared, chilled 80% ethanol,
incubating the 96-well plate on the magnetic stand for 30 s, and removing the supernatant
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from each well. Residual ethanol was removed by aspiration and the 96-well plate was
allowed to air dry for no longer than 10 min. The 96-well plate was removed from the
magnetic stand and 52.5 μL of Resuspension Buffer (RSB, Illumina) were added to each
of the wells. The 96-well plate was then placed in the plate shaker for 2 min at 1800 RPM
and incubated at room temperature for 2 min to elute the libraries off of the beads. The
96-well plate was placed on a magnetic stand for 2 min and 50 μL of each of the samples
were transferred to a new 96-well PCR plate.
Twenty microliters of each sample were transferred to a new 96-well midi plate
for bead-based normalization of the libraries. Eight-hundred and twenty-five microliters
of Library Normalization Additives 1 (LNA1, Illumina) and 150 μL Library
Normalization Beads 1 (LNB1, Illumina) were added to a 15 mL Falcon™ tube and
inverted 3X to mix. Forty-five microliters of the LNA1/LNB1 mixture were added to
each well in the 96-well midi plate that contained libraries. The 96-well midi plate was
placed in a plate shaker for 30 min at 1800 RPM and then on a magnetic stand for 2 min
and the supernatant was removed and discarded. The libraries were washed by repeating
the following steps twice: 45 μL of Library Normalization Wash 1 (LNW1, Illumina)
were added to each well, the plate was placed in a plate shaker for 5 min at 1800 RPM,
the plate was placed on a magnetic stand for 2 min, and the supernatant was removed and
discarded. Following the wash steps, 30 μL 0.1N NaOH were added to each well. The
plate was shaken at 1800 RPM for 5 min.
A new 96-well hard-shell PCR plate was labeled SGP (Storage Plate) and 30 μL
LNS1 (Library Normalization Storage buffer 1) were added to each well and the plate
was set aside. After the 96-well midi plate finished shaking, samples were resuspended
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by mixing with a pipette. The 96-well midi plate was shaken again at 1800 RPM for 5
min. The plate was incubated on a magnetic stand for 2 min and the supernatant was
transferred to the SGP plate, which was subsequently centrifuged at 1000 x g for 1 min.
Libraries were pooled by transferring 5 μL of each library to a 1.5 mL Lo-bind
microcentrifuge tube (Eppendorf, Hamburg, Germany) labeled “PAL” (pooled amplicon
libraries).
After libraries were pooled, they were diluted and denatured following the
manufacturer’s instructions (Denature and Dilute Libraries Guide for MiniSeq System,
rev Jan. 2016). Three microliters from the PAL tube were transferred to a 1.5 mL tube
containing 997 μL of prepared Hybridization Buffer (Illumina). The tube was vortexed
and briefly centrifuged. Two-hundred and fifty microliters were transferred to a new 1.5
mL tube. Two-hundred and fifty microliters of Hybridization Buffer were added and the
tube was vortexed and briefly centrifuged. The tube was then placed on a heating block
for 2 min at 98°C and then immediately on ice for 5 min.
A PhiX control library was spiked into the pooled libraries, as recommended by
Illumina, which can aid in assessing the quality of the sequencing run and troubleshoot
potential issues (e.g. unsuccessful library prep). A 10 nM PhiX stock library (Illumina)
was thawed and 10 μL were combined with 15 μL of RSB resulting in a 4 mM PhiX
library. This tube was vortexed and centrifuged briefly. The library was denatured by
combining 5 μL of the 4 mM PhiX library and 5 μL of 0.1N NaOH in a new tube, which
was vortexed and centrifuged briefly. The tube was incubated at room temperature for 5
min and 5 μL 200 mM Tris-Cl (pH 7) were added to the tube, vortexed, and centrifuged
briefly. Nine-hundred and eighty-five microliters of chilled hybridization buffer were
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added to the tube of denatured PhiX library resulting in a 20 pM PhiX library. The library
was diluted further by combining 45 μL of 20 pM PhiX library and 455 μL of
hybridization buffer in a new tube, which was vortexed and centrifuged briefly, resulting
in a 1.8 pM PhiX library. Twenty-five microliters of the 1.8 pM PhiX library were
combined with 475 μL of the diluted, pooled libraries to aim for a 5% PhiX library spikein rate.
Pooled libraries (including PhiX spike-in) were loaded into a MiniSeq High
Output Reagent Cartridge (300-cycles) and sequenced on an Illumina MiniSeq for a total
of 26 hrs. Following the sequencing run, raw image data files were translated into
nucleotides (basecalled), de-multiplexed (i.e. separated according to barcodes), and
adapter trimmed using the built-in Generate FASTQ analysis workflow to produce
paired-end reads.
Library preparation for Oxford Nanopore MinION sequencing. Six MinION
libraries were prepared using 1 to 1.5 μg of digested (RNAse A, PS, and partial Sau3AI
digested) plasmid DNA (53.5 μL @ 18.7 to 28 ng/μL) per sample (with the exception of
one sample being a genomic DNA sample for an unrelated project). The 1D Ligation
Sequencing Kit (SQK-LSK108, ONT, Oxford, UK) and 1D Native Barcoding Kit (PCRfree) (EXP-NBD103, ONT) were used to prepare and barcode the libraries. Care was
taken throughout the library prep to minimize the amount of pipetting done in order to
limit the amount of shearing of the DNA.
Prior to MinION library preparation, the optional FFPE DNA repair kit (NEB)
was used to repair nicks in the DNA molecules. Fifty-three and a half microliters of each
sample (at 18.7 - 28 ng/μL) were mixed with 6.5 μL FFPE repair buffer and 2 μL of
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FFPE repair enzyme mix. For plasmids pCCP1 and pCCP2, the volumes of the FFPE
repair buffer and enzyme mix were increased proportionately to account for the larger
volume of pDNA samples. Tubes were mixed by gentle flicking and centrifuged briefly,
then incubated at room temperature for 15 min. Sixty-two microliters of Agencourt
AMPure XP beads (1X volume) were added to each sample and incubated at room temp
for a minimum of 5 min. Tubes were briefly centrifuged and placed on a magnetic rack to
pellet the beads for at least 2 min. The supernatant was removed and discarded. Two
hundred microliters of freshly prepared, chilled 70% ethanol were added to each tube,
with care taken not to disturb the pellet. Ethanol was removed and the ethanol wash was
repeated once more. After removing the ethanol, tubes were air dried for no longer than 5
min, removed from the magnetic rack, and 47 μL of MQ water were added to elute the
DNA off the beads. Tubes were gently flicked to resuspend the beads and the tubes were
incubated at room temp for at least 2 min and placed on the magnetic rack for 2 min until
the tubes cleared in color. Forty-six microliters were removed from each tube, with care
taken not to carry over beads, and transferred to new 1.5 mL Eppendorf Lo-bind tubes.
One microliter was removed from each sample and quantified on a Qubit 2.0
fluorimeter using the dsDNA BR assay kit according to the manufacturer’s instructions
(Invitrogen). The DNA was then subjected to an end-repair and dA-tailing reaction.
Forty-five microliters of FFPE-repaired DNA samples were mixed with 7 μL of Ultra II
end-prep reaction buffer (NEB), 3 μL of Ultra II End-prep enzyme mix (NEB), and 5 μL
MQ water. Tubes were gently flicked to mix and centrifuged briefly. Tubes were
incubated at room temperature for 5 min then at 65ºC for 5 min. Tubes were centrifuged
briefly, 60 μL of AMPure XP beads were added to each tube, and mixed by gentle
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flicking. Tubes were incubated at room temperature for at least 5 min to allow DNA to
bind to the beads and centrifuged briefly. Tubes were then placed on magnetic rack for at
least 2 min and the supernatant removed and discarded. Two-hundred microliters of
freshly prepared, chilled 70% ethanol were added to each tube, with care taken not to
disturb the pellet. Ethanol was removed, discarded, and the ethanol wash was repeated
once more. After residual ethanol was removed and tubes air dried, the tubes were
removed from the magnetic rack. Twenty-six microliters of MQ water were added to
elute the DNA. Tubes were gently flicked to mix and incubated for 5 min at room
temperature, then placed on the rack for 2 min, allowed to clear, and 26 μL of each
sample were transferred to new 1.5 mL Lo-bind tubes. One microliter of each sample was
quantified on the Qubit using the dsDNA BR assay kit according to the manufacturer’s
instructions (Invitrogen).
Barcodes were assigned to each sample as follows: BC01=pEG1-06, BC02
=pEG1-06 (duplicate of same sample), BC03=Staphylococcus gDNA (unrelated project),
BC04=pCCP1, BC05=pCCP2, BC06=pCCRT11-6. Five-hundred nanograms of each
sample were diluted with MQ water to a volume of 22.5 μL. Two and a half microliters
of a native barcode, BC01-BC06, (ONT) were added to each tube, followed by 25 μL
Blunt/TA Ligase Master Mix (NEB). Tubes were gently flicked to mix and centrifuged
briefly. Tubes were incubated for 10 min at room temperature. Fifty microliters of
AMPure XP beads (1X volume) were added to each tube, gently flicked to mix, and
centrifuged briefly. Tubes were incubated at room temperature for at least 5 min and then
placed on a magnetic rack for 2 min. Supernatants were removed and discarded and 200
μL of fresh, chilled 70% ethanol were added to each tube. Ethanol was removed and
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another 200 μL of 70% ethanol were added and subsequently removed. Residual ethanol
was removed and tubes air dried for no longer than 5 min. Tubes were removed from the
magnetic rack and 27 μL of MQ water were added to the tubes to elute the DNA. Tubes
were gently flicked to mix before placing them back on the magnetic rack for 2 min.
Twenty-six microliters of each sample were transferred to new 1.5 mL Lo-bind tubes,
with care taken not to carryover beads. One microliter was removed from each sample
and quantified on the Qubit using the dsDNA BR assay kit according to the
manufacturer’s instructions.
Samples were pooled in equimolar amounts to a total of 700 ng and diluted with
MQ water to a total volume of 50 μL. Twenty microliters of BAM (Barcode Adapter
Mix, ONT) were added to the tube, followed by 20 μL Quick Ligation Reaction Buffer
(5X) (NEB), and 10 μL of Quick T4 DNA Ligase (NEB). The tube was gently flicked to
mix, centrifuged briefly, and then incubated for 10 min at room temperature before
adding 40 μL of AMPure XP beads. The tube was gently flicked to mix and incubated at
room temperature for 5 min, then placed on a magnetic rack for 2 min and the
supernatant removed. One-hundred and forty microliters of ABB (Adapter Bead Bind
buffer, ONT) were added to the tube and beads were resuspended by gently flicking the
tube. The tube was placed back on the magnetic rack and incubated for at least 2 min for
the beads to pellet. Supernatant was removed and another 140 μL of ABB were added.
Beads were resuspended by removing the tube from the rack and gently flicking to mix.
Then beads were pelleted on the magnetic rack, and the supernatant was removed. The
tube was removed from the magnetic rack, 15 μL of elution buffer (EB, ONT) were
added, gently flicked to mix, and the tube incubated for 10 min at room temperature. The
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tube was placed on the magnetic rack and allowed to pellet for at least 2 min. Fifteen
microliters of the pooled libraries were transferred to a new 1.5 mL Lo-bind tube. This
pooled library was stored on ice until loading into the flowcell.
MinION flowcell priming and loading. Prior to loading the library, an R9.4
SpotON Flowcell (FLO-MIN106, ONT) was primed according to the manufacturer’s
instructions. The priming port cover was slid open and a P1000 pipette was used to draw
back a small amount (~20-30 μL) of buffer, being careful not to introduce any air into the
flowcell. Flowcell priming mix was prepared by mixing 524 μL RBF (Running Buffer
with Fuel Mix, ONT) with 624 μL of MQ water. Eight hundred microliters of priming
mix were slowly loaded into the flowcell via the priming port, with care being taken not
to introduce air bubbles. After 5 min, the SpotON port was removed and 200 μL of
priming mix were added via the priming port. In a new Lo-bind tube, 35 μL RBF were
mixed with 2.5 μL MQ water, 25.5 μL LLB (Library Loading Beads, ONT), and 12 μL of
the pooled library. Using a P200 pipette, the library was then gently mixed by pipetting
and loaded to the SpotON port in a dropwise fashion, ensuring each drop flowed into the
flowcell prior to the next drop falling.
A sequencing run was set up using MinKNOW software (v. 1.10.16) using the
built-in python script “NC_48Hr_sequencing_FLO-MMIN106_SQKLSK108_plus_basecaller.py” (protocols v. 1.10.11.1). After 8 hrs of sequencing, 18.75
μL of the prepared library (8.75 μL RBF + 0.6 μL MQ water + 6.4 μL LLB + 3 μL
pooled library) were added to the flowcell using the technique described above. MinION
sequencing is typically carried out for 48 hours to maximize the data yield from the
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flowcell, however the run was stopped after approximately 16 hours because the
nanopores on the flowcell had degraded and stopped producing data.
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Results
Plasmid extraction. Plasmids were extracted using a procedure developed in our
laboratory for the isolation of large, low-copy plasmids (Gehr, 2013). The protocol is
alkaline lysis-based and was used for isolating plasmids ranging in size from
approximately 58-121 kb. The extraction results in pure, RNA-free plasmid DNA
(pDNA) as indicated by the OD260/280 and OD260/230 ratios measured using a Synergy
H1 Multi-Mode Reader. All pDNA samples used for downstream applications had
OD260/280 ratios between 1.8-2.0 and OD260/230 ratios of 2.0-2.2, which is generally
accepted as pure for DNA samples (Sambrook, 2006).
Pre-library preparation plasmid DNA treatment. Prior to the sequencing of
plasmid DNA samples on both the MiniSeq and MinION, steps were taken to remove
RNA and chromosomal DNA as well as to linearize circular pDNA molecules. RNA was
removed using RNase A and chromosomal DNA was removed using Plasmid-Safe
DNase (PS), an exonuclease designed to digest any non-circular DNA, and was verified
through gel electrophoresis (Figure 2). Lanes 2 and 3 were loaded with pEG1-06 DNA
that was extracted from electroporated (EC100) cells using the plasmid extraction
protocol and treated with RNAse A. RNA was not observed in either of the samples. The
sample in lane 3 was additionally treated with PS and two bands were observed. The
lower band at approximately 23.1 kb is the supercoiled form of the plasmid and the other
band (>23.1 kb) is the relaxed circle form of the plasmid (Figure 2).
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Figure 2. Plasmid DNA extracted from EC100 cells containing pEG1-06, visualized on a
1% agarose gel stained with GelRed. Lane “L” lane: lambda/HindIII digest. Lane 2:
pDNA sample of pEG1-06, treated with RNAse. Lane 3: the same sample as lane 2,
additionally treated with PS enzyme. Red line indicates where gel image was cut and
edited to remove unnecessary gel lanes.
Linearization of the pDNA was necessary for two reasons. (1) If the pDNA
molecules are in a supercoiled state, then the Qubit dsDNA-specific dye will not be able
to efficiently bind to the pDNA, thus resulting in erroneous pDNA concentration readings
(personal communication, ThermoFisher). (2) To successfully prepare pDNA for
MinION sequencing, linear DNA molecules are required for the ligation of sequencing
adapters on to the ends of the DNA fragments.
Restriction enzyme digestion of plasmid DNA for sequencing. Following
plasmid extraction and treatment with RNAse A and PS, the plasmids were digested with
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EcoRI and verified via agarose gel electrophoresis (Figure 3). Fragmentation was
performed enzymatically using the restriction enzyme EcoRI prior to the Nextera XT
DNA library preparation required for Illumina sequencing. The tagmentation reaction is
the first step of the Nextera XT DNA library preparation which fragments DNA and
ligates adapters to the fragments using a transposome. This reaction is very sensitive to
DNA concentrations and can over-fragment or under-fragment if the initial quantity of
DNA is higher or lower than the required 1 ng of DNA. Thus, to obtain accurate pDNA
concentrations, we fragmented the pDNA prior to quantification with the QubitTM
fluorometer (Invitrogen, Thermo Fisher Scientific Inc).
Lane 2 contains pEG1-06 after treatment with PS enzyme and lane 3 contains the
same sample as lane 2 but additionally digested by EcoRI (Figure 3). Lanes 4-5, 6-7, and
8-9 contain pCCP1, pCCP2, and pCCRT11-6 samples treated with PS and the same
samples after EcoRI digestion, respectively. RNAse A was not added to the samples in
lanes 2-5, and RNA can be seen in the bright patches below 564 bp. RNAse A was added
to the samples in lane 6-9, and no RNA was observed. RNAse A was added to the
samples in lane 3 and 5 prior to the MiniSeq library prep protocol.
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Figure 3. Plasmid DNA treated with Plasmid-Safe enzyme before (even lanes) and after
(odd lanes) restriction digestion with EcoRI for Illumina MiniSeq library preparation.
Samples treated with RNAse A in lanes 6-9. Lane L: lambda/HindIII digest marker,
Lanes 2-3: pEG1-06, Lanes 4-5: pCCP1, Lanes 6-7: pCCP2, Lanes 8-9: pCCRT11-6.
Oxford Nanopore Technologies recommends that if one plans on performing the
optional step of DNA fragmentation prior to the library preparation, that they use a GtubeTM (Covaris, Matthews, NC). The G-tubeTM mechanically fragments the DNA by
using centrifugal force to move the sample through a precisely manufactured orifice. Our
previous attempts to fragment pDNA with a G-tubeTM, resulted in a MinION sequencing
run that generated almost zero reads and it was hypothesized that the supercoiled state of
pDNA did not allow successful fragmentation using the G-tubeTM, thus we opted to
fragment the plasmids enzymatically prior to the library preparation (Libuit, 2016).
A “partial” digestion with Sau3AI, in this context, means that the step for
incubating the tubes at 37°C was removed completely, to reduce the enzyme’s activity on
the pDNA molecules. This was done in an attempt to fragment the pDNA as little as
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possible, allowing for ligation of ONT sequencing adapters, but also to yield larger
pDNA fragments than if a complete digestion was performed. Sau3AI was chosen
because the enzyme recognizes a 4 bp restriction site (5’-GATC-3’), which will typically
digest pDNA molecules more frequently than a 6-base cutter, so when the enzyme’s
activity is reduced, the partial digestion will yield a wide distribution of fragment sizes
from 500bp up to the total size of the plasmid.
Following (scaled-up) plasmid extraction and treatment with PS and RNase A, the
plasmids were partially digested with Sau3AI and visualized using agarose gel
electrophoresis (Figure 4). Lane 2 contains pEG1-06 DNA treated with RNAse A and PS
enzyme. Two bands can be seen, one at 23.1 kb that is the supercoiled form of the
plasmid and the second, brighter band above 23.1 kb that is the relaxed circle form of the
plasmid. Two bands can also be seen in lanes 4, 6, and 8 that are the supercoiled and
relaxed circle forms of pCCP1, pCCP2, and pCCRT11-6, respectively. The relative sizes
of the plasmids are reflected in lanes 2, 4, 6, and 8 as the relaxed circle bands for pCCP1
and pCCP2 (lanes 4 and 6, respectively) appear to migrate at the same (fastest) rate,
while the relaxed circle band for pEG1-06 (lane 2) is higher up, and the relaxed circle
band for pCCRT11-6 is highest.
Lane 3 contains the same pEG1-06 sample that is in lane 2, but partially digested
with Sau3AI. A smear is observed from ca. 23 kb down (Figure 4). Lanes 4-5, 6-7, and 89 contain plasmids pCCP1, pCCP2, and pCCRT11-6 respectively, before and after partial
digestion with Sau3AI (Figure 4). A smear is also observed in lanes 5, 7, and 9, however
the smear is much lighter, indicating a lower quantity of pDNA present. They also appear
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to have a lower average molecular weight, suggesting the plasmids were digested more
frequently with Sau3AI.

Figure 4. Plasmid DNA treated with Plasmid-Safe and RNAse A before (even lanes) and
after (odd lanes) partial restriction digestion with Sau3AI for Oxford Nanopore library
preparation. Lanes L: lambda/HindIII digest, lanes 2-3: pEG1-06, lanes 4-5: pCCP1,
lanes 6-7: pCCP2, lanes 8-9: pCCRT11-6.
Library preparation. Once pDNA was extracted from EC100 cells and digested
(RNAse A, PS, and either EcoRI or Sau3AI partial digestion), libraries were prepared for
sequencing on an Illumina MiniSeq and an Oxford Nanopore MinION. Prior to library
preparation, sample purity was verified to check for an OD 260/280 ratio between 1.8 and
2.0 and an OD 260/230 ratio between 2.0 and 2.2. For MiniSeq sequencing, digested
plasmid DNA samples were diluted and quantified using the Qubit dsDNA HS kit (Table
1). Samples were then diluted further to 1 ng in 5 µL (0.2 ng/µL).
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Table 1. pDNA concentrations prior to Illumina library preparation. Concentrations were
measured using the Qubit fluorimeter.
Plasmid
DNA concentration (ng/µL)
pEG1-06
0.55
pCCP1
2.08
pCCP2
0.63
pCCRT11-6
1.31
For MinION sequencing, digested pDNA samples were concentrated using
Agencourt AMPure XP beads and quantified using the Qubit dsDNA BR kit (Table 2).
pEG1-06 replicate 2 was diluted to 1.5 µg in 53.5 µL (28 ng/µL). pEG1-06 replicate 1
and pCCRT11-6 samples were not diluted further. pCCP1 and pCCP2 samples had the
minimum required quantity of DNA (1000 ng) but the DNA concentrations were too low.
To mitigate this during the ONT library preparation, the volumes of reagents during first
reaction (FFPE DNA repair) were increased proportionately to compensate for the higher
volume of the pDNA samples.
Table 2. pDNA concentrations prior to Oxford Nanopore Library preparation.
Concentrations were measured using the Qubit fluorimeter.
Plasmid
DNA concentration (ng/µL)
pEG1-06 replicate 1

23.4

pEG1-06 replicate 2

29.5

pCCP1

16.5

pCCP2

19.4

pCCRT11-6

27.0

MiniSeq sequencing run. Libraries were prepared using digested plasmid DNA
and were sequenced on an Illumina MiniSeq sequencer. During the first few cycles of the
sequencing run, single stranded DNA libraries hybridize with the flowcell and are
clonally amplified while immobilized on the flowcell to produce “clusters” of clonally
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amplified libraries. Clusters are then detected, mapped, and are subjected to a quality
filter to remove the least reliable clusters from analysis (Illumina, 2016). Reads that are
generated from the clusters that passed the quality filter are called “reads passed filter
(PF).” Cluster density is a measure of signal intensity (emitted light) in a given area on
the MiniSeq flowcell (resulting from clusters in close proximity) and the metric can
influence run quality, reads passing filter, read quality scores, and total data output. For
the MiniSeq the optimal range of cluster density set by Illumina is 170-220 K
clusters/mm2 and the cluster density from this sequencing run was 110 ± 2 K
clusters/mm2 indicating underclustering of the flowcell (Table 3).
Table 3. MiniSeq sequencing run statistics.
Total bases sequenced
Total # of reads
# of reads Passed Filter (PF)
Percent of reads
identified/sample (PF)
# of bases ≥ Q30 (PF) (%)
Cluster density
% PhiX

pEG1-06
964,110

5.51 Gb
18,544,771
17,546,094
pCCP1
pCCP2
506,701
653,046

5.4947 %

2.8878 %

3.7218 %

pCCRT11-6
753,409
4.2938 %

5370.1 Mb (96.36 %)
110 ± 2 K clusters/mm2
11.98 %

Another important metric for assessing the quality of a MiniSeq sequencing run is
the percentage of reads that uniquely aligned to the PhiX reference genome. PhiX is often
spiked into the pooled libraries as a control library to troubleshoot potential issues such as
failed library preparations but also can be useful when there is low nucleotide “diversity”
among samples (e.g. sequencing amplicons with high % GC content). The percentage of
reads aligned to PhiX was 11.98%, which is higher than the expected 5%, but nonetheless
acceptable (Illumina, 2016) (Table 3).
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Phred quality score (or simply Q score) is the metric used for sequence read
accuracy and has an inverse, logarithmic relation to the probability of error of a base call
(Ewing and Green, 1998). For example, Q10 indicates the probability that 1 of every 10
base calls will be an error (10% error rate); Q20 indicates the probability that 1 in 100
base calls will be an error (1% error rate); Q30 indicates the probability that 1 in 1,000
base calls will be an error (0.1% error rate).
The MiniSeq sequencing run generated a total of 5.51 Gigabases (Gb) of
sequence data in 18,544,771 paired-end (PE) reads with an average read length of 150 bp.
17,546,094 of these reads passed the filter and 96.36% of all bases sequenced had a Q
score ≥ 30 (Table 3, Figure 5). Average Q scores across all nucleotide positions in all of
the reads ranged from 32.85 - 36.62 (Figure 6).

Figure 5. Distribution of Q scores for all bases sequenced during the MiniSeq run. Blue
bars indicate bases with a Q score < 30 and green bars indicate bases with a Q score ≥ 30.
Reads were de-multiplexed and adapters and barcodes were removed using the
Generate FASTQ analysis workflow. The pEG1-06 sample had the highest number of
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reads (among the 4 plasmid samples, not including the 12 other samples) with 964,110
PE reads (5.4847% reads PF) (Table 3, Figure 7). The pCCRT11-6 sample had the
second highest amount of reads with 753,409 PE reads (4.2938% reads PF). The pCCP2
and pCCP1 samples had the 3rd and 4th highest amount of reads with 653,046 (3.7218%
reads PF) and 506,701 PE reads (2.8878% reads PF), respectively (Table 3, Figure 7).

Figure 6. Average Q scores for each nucleotide position in the Illumina reads. Eight lines
are plotted and each line represents either the forward or reverse reads for each of the 4
samples. Plot was generated using MultiQC (Ewels et al., 2016).
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Figure 7. Percentage of reads identified for each index (barcode). Index assignments are
as follows: index 1: pEG1-06, index 2: pCCP1, index 3: pCCP2, index 4: pCCRT11-6,
indices 5-16: unrelated samples.
MinION sequencing run. Libraries were prepared using digested pDNA and
were sequenced on a MinION sequencer. Nanopore sequencers measure picoampere (pA)
level changes in ionic current as single stranded DNA (ssDNA) molecules pass through a
nanopore, and these measurements are considered “raw signal trace” data (file type:
fast5). When a molecule of ssDNA passes through a pore, the raw signal data is recorded
and considered as a single 1D read. The 16 hr sequencing run generated 220,775 reads
containing approximately 459 Mb of sequence data (Figure 8a; Table 4). After 16 hrs of
sequencing, the nanopores present in the flowcell had degraded and the device stopped
producing data (Figure 8a). The sequencing run was stopped and the raw signal data was
basecalled into nucleotides using Albacore (ONT official basecalling software,
https://community.nanoporetech.com/downloads) resulting in fastq files.
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Table 4. MinION sequencing run general statistics. Statistics were calculated using
Porechop and NanoPlot.
Total # of
459,280,985 bases
bases
sequenced
220,775
pEG1-06
pEG1-06
pCCP1
pCCP2
pCCRT11-6
# of reads
replicate 1
replicate 2
13,799
39,727
29,717
18,931
62,671
# of
39,653,462 138,396,462 30,941,099 19,766,071 81,471,888
bases/sample
Mean read
2,080
length (bases)
pEG1-06
pEG1-06
Mean read
pCCP1
pCCP2
pCCRT11-6
replicate 2
length/sample replicate 1
(bases)
2,958.7
3,572.7
1,137
1,130.3
1,399.1
Median read
1,093 bases
length (bases)
pEG1-06
pEG1-06
Median read
pCCP1
pCCP2
pCCRT11-6
replicate 2
length/sample replicate 1
(bases)
1,550
1,972
914
909
998
Mean read Q
9.1
score
Median read
9.5
Q score
# reads >Q7
191,729 (86.8%), 410.2 Mb
(%), Mbases
# reads >Q10
74,744 (33.9%), 175.8 Mb
(%), Mbases
127,065 bases
Longest read
3,636 bases
Read N50
# of active
437 out of 512 channels
channels
Elapsed time
16 hrs
of seq. run

The mean read length for all the reads was 2,080 bases, the median read length
was 1,093 bases, and the read N50 was 3,636 bases (Figure 8b, Table 4). Read N50 is
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defined as the read length such that the reads of this length or greater sum to at least half
of the total bases in all reads (Jain et al., 2018).

Figure 8. (a) Cumulative yield of sequence data over the length of sequencing run. The
increase in slope at 8 hrs is due to the loading of additional library to the flowcell after 8
hours of sequencing. (b) Read length distribution with read N50 line at 3,636 bases. Both
plots were generated using NanoPlot (De Coster, 2017).
Reads were de-multiplexed using both Albacore and Porechop
(https://github.com/rrwick/porechop) and barcode sequences were removed from the
reads using Porechop. The first pEG1-06 replicate had 13,799 reads containing a total of
39,653,462 bases with a mean read length of 2,958.7 bases and a median read length of
1,550 bases (Table 4, Figure S1). The second pEG1-06 replicate had 39,727 reads
containing a total of 138,396,462 bases with a mean read length of 3,572.7 bases and a
median read length of 1972 bases (Table 4, Figure S2). pCCP1 had 29,717 reads
containing a total of 30,641,099 bases with a mean read length of 1,137 bases and a
median read length of 914 bases (Table 4, Figure S3). pCCP2 had 18,931 reads
containing a total of 19,766,071 bases with a mean read length of 1,130.3 bases and a
median read length of 909 bases (Table 4, Figure S4). pCCRT11-6 had 62,671 reads

45
containing a total of 81,471,888 bases with a mean read length of 1,399.1 bases and a
median read length of 998 bases (Table 4, Figure S5).
The mean read Q score for all ONT reads was 9.1 and the median read Q score
was 9.5 (Figure 9, Table 4). 191,729 (86.8%) of the reads (which contain 410.2 Mb) had
a Q score greater than 7 (Table 4). Q7 represents approximately a 19.9% error rate.
74,744 (33.9%) of the reads (which contain 175.8 Mb) had a Q score greater than 10.
pEG1-06 replicate 1 reads had a mean Q score of 9.6 and a median Q score of 9.8 (Figure
S6). pEG1-06 replicate 2 reads had a mean Q score of 9.5 and a median Q score of 9.7
(Figure S7). pCCP1 reads had a mean Q score of 9.6 and a median Q score of 9.8 (Figure
S8). pCCP2 reads had a mean Q score of 9.6 and a median Q score of 9.7 (Figure S9).
pCCRT11-6 reads had a mean Q score of 9.6 and a median Q score of 9.8 (Figure S10).

Figure 9. Mean read quality score distribution for all reads from the MinION sequencing
run. The highest average quality score from a read was 12.62. Median quality score was
9.5, mean quality score of all reads was 9.1.
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Discussion
Plasmid extraction and pre-sequencing treatment. In this study, we present a
method for quickly and efficiently isolating plasmid DNA (pDNA) without the use of a
commercial plasmid extraction kit, and methods for the treatment of pDNA samples prior
to sequence library preparation for Illumina and Oxford Nanopore DNA sequencing.
These methods include the isolation of pDNA by alkaline lysis, removal of chromosomal
DNA by Plasmid-Safe digestion, enzymatic fragmentation of pDNA, accurate
quantification of pDNA using fluorometric methods, and library preparation using the
Nextera XT DNA library prep kit for Illumina sequencing and the PCR-free 1D Ligation
library prep kit for ONT sequencing. We demonstrate the efficacy of this method by
preparing and sequencing four large, tetracycline-resistance plasmids on both sequencing
platforms.
Traditional plasmid sequencing strategies involve plasmid DNA purification and
shotgun sequencing; however, purification of large plasmids (> 50 kb) is typically
difficult, time-consuming, and can be expensive if commercial kits are used to extract the
plasmids (Smalla et al., 2015). Our method of plasmid extraction by alkaline lysis allows
one to quickly obtain pure pDNA from plasmids up to ~122 kb in size (up to 300 kb,
unpublished) from a broth culture in approximately 1-1.5 hrs. This technique yields pure
pDNA samples that are free of RNA, protein, and salts that may inhibit downstream
applications that are sensitive to contaminants (e.g. library preparation and DNA
sequencing). This extraction technique has primarily been used in our lab to extract from
E. coli and Salmonella enterica (Gram-negative bacteria) cells however this can also be
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applied to extracting pDNA from Gram-positive genera such as Staphylococcus,
Enterococcus, and Bacillus.
When the plasmid extraction technique was scaled up to extracting from larger
volume cultures (e.g. 30 mL broth cultures), we were able to extract sufficient quantities
of DNA for ONT sequencing, which require 400-1000 ng of total DNA (depending upon
the type of ONT library prep kit used). It is often difficult to obtain sufficient quantities
of plasmid DNA, especially if the plasmid is of low-copy number. One additional method
to aid in increased pDNA yields (from plasmids expressing antibiotic resistance) is to
amend the broth cultures with an antibiotic to ensure that all cells contain the plasmid of
interest.
Researchers that aim to characterize the total plasmid content from a given
environment the will often sequence the “meta-plasmidome” where expected pDNA
yields are low after extraction, and because of the low yields, amplification strategies are
typically employed to increase pDNA quantities prior to sequencing. Phi29 polymerase
rolling circle amplification has been used to amplify circular DNA molecules (which
inherently excludes chromosomal DNA) (Kav et al., 2013). The disadvantage to this
approach is that there are known biases with rolling circle amplification, as the
amplification will increase the abundance of smaller plasmids over that of large plasmids
(Norman et al., 2014). This bias can be reduced, but at the cost of an extra step to
separate plasmids based on their size prior to amplification.
Removal of chromosomal DNA. Our alkaline lysis-based plasmid extraction
technique typically yields sufficient quantities of pDNA for many downstream
applications; however there are still small amounts of chromosomal DNA which carry
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over into the final sample. To remove the chromosomal DNA, we elected to use an
exonuclease, Plasmid-Safe ATP-dependent DNase, to digest linear chromosomal DNA.
This enzyme works well for digesting linear fragments of chromosomal DNA and this
removal can then be visualized on a standard agarose gel (Figure 2). There are some
disadvantages to this approach. Any linear plasmid forms will be digested and lost.
Plasmid typically exist in three conformations: (1) supercoiled conformation, where the
DNA is tightly coiled and occupies the smallest volume of space within cells, (2) relaxed
circle conformation where one of the two strands of pDNA has been nicked, allowing for
the uncoiling of the pDNA molecules, and (3) linear, where both pDNA strands have
been broken and the plasmid is completely uncoiled. Also, Plasmid-Safe digestion does
require some form of sample purification prior to sequencing, although if the DNA is
being used downstream for sequencing, the DNA purification steps typically necessary
for library preparation will be sufficient.
In this study, we followed the manufacturer’s instructions of incubating the
plasmid-safe reaction at 37ºC for 30 minutes, with the goal of removing all chromosomal
DNA. After sequencing, it was clear that some E. coli chromosomal material did get
sequenced along with our plasmids of interest due to the presence of contiguous
sequences that aligned with near 100% identity to an E. coli reference genome. This may
have confounded the plasmid genome assemblies and allowed for assembly errors to
occur, but this will be addressed in the Chapter 2 Results and Discussion section. We
therefore recommend extending the 37ºC incubation to 1.5 hrs or longer to ensure the
complete digestion of linear chromosomal DNA. In addition to visual confirmation of
chromosomal DNA removal on an agarose gel, 16S rRNA PCR can be performed on the
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samples, post-Plasmid-Safe treatment, to see if any chromosomal fragments remain
undigested (Kav et al., 2013).
Enzymatic fragmentation of pDNA. Accurate quantification of DNA samples is
critical for sequencing, especially when using the Nextera XT library preparation kit
where successful preparation of sequencing libraries is highly dependent on the input
quantity of DNA (Illumina, 2016). The tagmentation reaction is the first step of the
Nextera library prep which fragments DNA and ligates adapters to the fragments using a
transposome. This reaction is sensitive to DNA concentrations and can over-fragment or
under-fragment if the initial quantity of DNA is higher or lower than the required 1 ng of
DNA, leading to low quality sequence runs.
We opted to enzymatically fragment the plasmids prior to sequencing, allowing
for accurate quantification using the Qubit fluorimeter (personal communication,
ThermoFisher) and to allow for the ligation of ONT sequencing adapters during the 1D
Ligation library preparation protocol. We used enzymatic fragmentation rather than the
ONT recommended mechanical fragmentation with a Covaris G-tube, due to a failed
plasmid sequencing run that was likely caused by unsuccessful shearing of pDNA
molecules prior to the library preparation protocol. (Libuit, 2016). It was hypothesized
that the supercoiling state of the plasmid, caused the pDNA to pass through the G-tubes’
orifice without fragmenting the pDNA molecules. Without free ends of pDNA fragments,
ONT sequencing adapters could not be ligated, thus the pDNA is not sequenceable.
Enzymatic fragmentation of the four plasmids, pEG1-06, pCCRT11-6, pCCP1, and
pCCP2 was performed using the restriction enzyme Sau3AI prior to ONT sequencing.
The read lengths produced by ONT sequencers are highly dependent upon the size of the

50
input fragment lengths, allowing for long read lengths (in our case, up to the total size of
the plasmids) (Jain et al., 2018). The partial digestion of plasmids dictated the resulting
read lengths and they varied depending on the plasmid. For pEG1-06 digested by Sau3AI
and visualized on a gel, we observed a smear ranging from ca. 23 kb down (Figure 4, lane
3) and a wide distribution of read lengths were reflected in the ONT data with reads up to
61 kb and a mean read length of 3.2 kb (Supplementary Figure S2). Plasmid pCCP2 was
digested more frequently than pEG1-06, and this was likely due to either a lower quantity
of pDNA prior to the digest than the pEG1-06 sample or the presence of more Sau3AI
restriction sites being present in the pCCP2 genome (Figure 4, lane 7). This plasmid
resulted in the shortest ONT mean read lengths of 1.1 kb; the longest read was 37.1 kb
(Supplementary Figure S4).
For plasmid sequencing experiments using a ONT sequencer, we recommend
experimenting with various restriction enzymes, with the goal of fragmenting the
plasmids as little as possible in order to take advantage of the long read lengths of the
MinION. Despite fragmenting the plasmids to sizes smaller than we had hoped, the reads
were long enough to allow for the complete assembly of the genomes (Chapter 2 Results
and Discussion: Figure 15, p. 74). Mechanical fragmentation methods may be more
consistent in achieving longer read lengths, though these protocols would have to be
optimized for plasmids due to the tendency of plasmids to form supercoils, which can be
resistant to mechanical shearing methods. Regardless of plasmid fragmentation
technique, we recommend assessing fragment length distributions by visualization on an
agarose gel or using a Bioanalyzer prior to ONT library preparation.
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MiniSeq sequencing. The data produced by the MiniSeq sequencing run was of
very high quality (96.3% of bases sequenced ≥ Q30) however the sequencing run yielded
approximately 5.5 Gb of sequence data, which was lower than the theoretical maximum
of that the MiniSeq is capable of producing - 7.5 Gb. This was likely the result of the
underclustering of the flowcell that was observed for the sequencing run (Table 3).
Underclustering of the flowcell was an indication that we underestimated the quantity of
the pooled sequencing libraries that were loaded into the sequencer, therefore the total
amount of sequence data produced was lower than the theoretical maximum, but this
allowed for the data to be of very high quality (Phred Quality scores). Often observed
with longer Illumina MiSeq reads (300 bp in length), there is a significant drop off in
quality scores when the last ~50 bases are sequenced, however the data produced
throughout the entire length of the sequencing run were ≥ Q32 (Figure 6) (Shendure and
Ji, 2008). Despite the attempt to normalize the concentrations of libraries prior to pooling
and loading of the flowcell, we observed an uneven amount of data produced by each
unique libarary, ranging from near 0% of read identified for a barcode, up to ~15% of
read identified for a single barcode (Figure 7). We believe this was due to an uneven
quantity of DNA going into the Nextera XT library prep, or the different libraries
hybridizing to the flowcell in different proportions, thus producing a varying amount of
data for each sample.
Nanopore sequencing. The quality of the data produced by the MinION
sequencing run was of typical for that of ONT data which is estimated to be 92%
accuracy for 1D reads (Jain et al., 2016). The reads produced by the MinION run had
mean Q score 9.1 (~87.7% accuracy), median Q score 9.5 (~88.8% accuracy) (Table 4).
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This MinION run produced approximately 0.459 Gb of sequence data, which is low
compared to the typical output of 3-5 Gb of sequence data typically produced by MinION
sequencing runs (Leggett and Clark, 2017) however this was not an issue due to the
relatively small size of the plasmid genomes and the high average depth of coverage
achieved for the assemblies. After assembling the plasmid genomes and aligning the
ONT reads back to the assemblies, the lowest average depth of coverage among the four
plasmids was high - at 105.8X for pCCP1 (Chapter 2: Results and Discussion, Table 7).
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Chapter 2
Exogenous capture, sequencing, characterization, and genomic analysis of four
antibiotic resistance plasmids captured from the stream sediments of agriculturallyimpacted streams in the Shenandoah Valley
Introduction
Large, self-transmissible plasmids are key vectors in the transfer of resistance,
catabolic, and other genes among bacteria native to environments such as streams and
wetlands (Herrick et al., 2014; Botts et al, 2017). The evolution of antibiotic resistance in
particular is known to be powerfully affected by conjugative plasmid transfer due to the
ability of plasmids to exchange mobile genetic elements such as transposons and
insertion sequences that often contain antibiotic resistance genes (Smillie et al., 2010).
This is further driven by the ease in which some plasmids can be horizontally transferred
into a broad host range of bacteria. The dissemination and evolution of antibiotic
resistance is largely driven by conjugative plasmids, so it is necessary to identify and
understand the characteristics and behavior that contribute to the spread of antibiotic
resistance among bacteria.
Traditionally, plasmids have been classified using conventional PCR-based
methods for typing based on backbone genes such as plasmid replication genes (replicon
typing) and mobility typing (MOB). However, the use of whole genome sequencing to
study plasmids in silico has prompted a shift in the field of plasmid biology towards
classifying plasmids based on their entire genomes instead of a single or a few loci (Orlek
et al., 2017). While replicon typing is useful for identifying incompatibility groups of
plasmids, whole (plasmid) genome sequencing offers a finer level of resolution and
allows for the differentiation of plasmids based on slight differences in nucleotide or
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amino acid sequence. For example, the differentiation of IncA/C2 type one and type two
variant group plasmids is based on single coding sequence (CDS) which differs only
slightly in length due to insertions and deletions. This CDS is located between the traA
gene and dsbC gene located within the hallmark Tra suite of genes involved in conjugal
transfer (Harmer and Hall, 2015). IncA/C2 type one variants contain the CDS that is
1,832 amino acids (AA) in length and IncA/C2 type two variants contain the CDS that is
1,847 AA in length.
The advent of whole genome sequencing has increased our understanding of the
extrachromosomal elements and they have been increasingly studied with the advent of
3rd generation long read sequencing technologies like Pacific Biosciences and Oxford
Nanopore Technologies sequencers (Li et al., 2018; Botts et al., 2017; George et al.,
2017). Long reads have enabled the complete assembly of many plasmids that are
difficult to assemble with short reads alone. During this study in which the sequencing,
genome assembly, and analysis of four plasmids were performed, we found assemblies
using short read sequence data alone was not enough to resolve the plasmid genomes
completely, and required the addition of long reads to obtain complete, circular
assemblies.
Here we present a study on the exogenous capture and characterization of four
transmissible, tetracycline resistance plasmids, one 71 kb IncP-1β multi-drug resistance
plasmid previously captured in 2006 (Gehr, 2013), two 59 kb IncP-9 tetracycline
resistance plasmids captured from Cooks Creek Park, and one 121 kb IncA/C2
tetracycline resistance plasmid captured from Cooks Creek Rt. 11. We describe the
complete nucleotide sequences of each of the four novel plasmids and compare their
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genomes to the closest related plasmids to gain insight into their genes, predicted
functions, and how they compare to plasmids of the same incompatibility groups.
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Methods
Sampling sites. Stream sediment samples were collected from four streams in the
Shenandoah Valley of Virginia: Muddy Creek, Cooks Creek, Pleasant Run and War
Branch (Figure 10). Muddy Creek runs through Hinton, Virginia originating in the
Allegheny Mountains and the sampling location is directly adjacent to a poultry
processing plant. Muddy Creek, Cooks Creek, and Pleasant Run were chosen due to their
historically high E. coli and coliform counts and the fact that they drain numerous cattle
pastures and poultry farms. War Branch is a tributary of Muddy Creek and is higher in
elevation, with no obvious agricultural impact.

Figure 10. Locations of the stream sediment sampling sites.
Sample collection. Sediment samples were collected in sterile 50 mL Falcon
tubes. The top layer of sediment was brushed away using a sterile spatula and the
Falcon® tube was used to scoop sediment into the tube. Samples were transported to the
lab on ice, stored at 4°C and processed within 24 hours.

57
Bacterial strains. Escherichia coli strain LA61 was used as the recipient in
exogenous plasmid captures (Gehr, 2013). LA61 is a plasmid-free, tetracycline-sensitive
(tetS), rifampin-resistant (rifR), strain previously isolated in our laboratory from Great
Lakes beach sand (Gallagher, 2007). Electrocompetent E.coli strain EC100 (Epicentre
Technologies, Madison, WI) cells were used for electroporation of captured tetR
plasmids. EC100 cells are plasmid-free and are also tetracycline-sensitive.
Exogenous plasmid capture. Transmissible, tetracycline resistance (tetR)
plasmids were captured using a method developed in our laboratory (Figure 11) (Herrick
et al., 2014), modified from the original method of Fry and Day (1990). Cells were
extracted from sediment samples to act as potential plasmid conjugation donors. Ten
grams of sediment from each sediment sample were mixed with 90 mL of sterile 0.1%
sodium pyrophosphate (pH 8) and agitated for 40 s. Sediment was allowed to settle at
room temperature for 5 min. One milliliter of liquid was centrifuged for 10 min at 5,800 x
g. The supernatant was removed and the remaining pellet was reconstituted with 1 mL of
phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8
mM KH2PO4, pH 7.4) and centrifuged for 10 min at 5,800 x g. The supernatant was
removed and the pellet was reconstituted with 500 µL of PBS.
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Figure 11. Exogenous Plasmid Capture method for capturing tetracycline resistance
plasmids from sediment. Plasmids were captured from stream sediment samples by
releasing cells from sediment and conjugating with a rifampicin-resistant strain of E. coli.
Donors and recipients were individually plated onto TSA plates containing either
rifampicin (50 μg/mL) or tetracycline (25 μg/mL) respectively, as negative controls (and
to account for spontaneous rifampicin resistance), and onto TSA as a positive control.
Transconjugants were selected on tetracycline-and rifampicin-amended medium.
Recipient strain LA61 (tetS, rifR), was cultured overnight in TSB at 37°C with
agitation (~180 RPM). One milliliter of the culture was centrifuged at 5,800 x g for 10
min and washed with PBS in the same manner as the donor cells from the sediment. The
resulting washed pellet was reconstituted in 500 µL of PBS.
The 500 µL volume of recipient cells was added to the centrifuge tube containing
the 500 µL volume of potential donor cells. Cells were gently mixed by inversion for 20
s. Two hundred microliters of donor/recipient cell mixture were transferred onto a sterile
0.45 µm cellulose acetate filter (Millipore Corporation, Billerica, MA) applied to a TSA
plate. The cells were allowed to conjugate for 24 hrs at 37°C. After incubation, the filter
was aseptically removed from the TSA plate and placed in a 50 mL Falcon® tube. Ten
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milliliters of PBS were added to the tube with the filter and vigorously vortexed for 3 min
to release cells from the filter.
Five hundred microliters of the supernatant were pipetted onto TSA plates
amended with rifampicin (50 μg/mL) and tetracycline (25 μg/mL) to select for
transconjugants. Donors and recipients were individually plated onto TSA plates
containing either rifampicin (50 μg/mL) or tetracycline (25 μg/mL) respectively, as
negative controls (and to account for spontaneous rifampicin resistance), and onto TSA
as a positive control. Putative transconjugant colonies were transferred to TSA plates
containing tetracycline (25 μg/mL) and incubated for 24 hrs at 37°C to verify tetracycline
resistance. Putative transconjugants were confirmed as LA61 using the BOX-PCR
repetitive sequence fingerprinting method used as described in Gehr (2013) and
Rademaker et al. (1998).
Plasmids were extracted from transconjugants using the plasmid preparation
protocol described in Chapter 1 Methods (p. 18) and electroporated into a control
recipient, EC100, to isolate single plasmids and to verify plasmid-borne tetracycline
resistance.
Electroporation. Plasmid DNA was electroporated into electrocompetent tets E.
coli strain EC100 (Epicenter Technologies, Madison, WI) using a 1 mm cuvette with a
Bio-Rad GenePulser Xcell electroporator according to the manufacturer’s instructions
(Bio-Rad, Hercules, CA). EC100 cells were maintained and prepared for electroporation
according to protocol 6.1.1 of the Bio-Rad Gene pulser instruction manual. Transformed
cells were plated on TSA plates amended with 25 μg/mL tetracycline to verify the
transformation of the cells with a tetR plasmid.
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Antibiotic susceptibility phenotyping. Modified Stokes assays were performed
as described by Herrick et al. (2014). Resistance phenotypes for the antibiotics
tetracycline (30µg), gentamicin (10 µg), ciprofloxacin (5 µg),
trimethoprim/sulfamethoxazole (23.75 / 1.25 µg), imipenem (10 µg), tobramycin (10µg),
kanamycin (30 µg), aztreonam (30 µg), ticarcillin (75 µg), piperacillin/tazobactam (100 /
10 µg), piperacillin (100 µg), and cefepime (30 µg) were assessed using a modified
Stokes disk diffusion assay (Figure 12; Herrick et al., 2014). Recipient EC100 control
and tetR transformants resulting from electroporation were cultured overnight in TSB.
Sterile swabs were used to apply turbid broth cultures to Mueller-Hinton agar plates
(Becton Dickinson). Electroporated plasmid-harboring cells were swabbed on the outer
sections of the plate and the plasmid-free recipient was swabbed in the center third.
Antibiotic diffusion disks were applied along the lines where the recipients and
electrotransformants meet. Plates were incubated for 24 hours at 37°C.

Figure 12. Modified Stokes Assay method for detecting decreased susceptibility
conferred by electroporated plasmids. Transformants (electrocompetent E.coli EC100)
strain and empty recipients (control) were applied to Mueller-Hinton media. Antibiotic
diffusion disks were then placed along the lines at which the transformants and recipients
meet. Resulting zones of inhibition of the transformants and the recipient were compared
to determine if the plasmid in the transformant encodes resistance to the antibiotic in the
diffusion disk. A reduction of ≥ 3 mm in the radius of the zone of inhibition was
designated as “resistant” to the antibiotic.
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The radii of clearing zones from the control side and the transformant side of the
disks were measured using a caliper and compared. A ≥ 3 mm reduction in the radium of
the zone of inhibition was considered an indication of resistance to the antibiotic (Acar
and Goldstein, 1996).
In vitro restriction digests. EcoRI in vitro restriction digests were performed
using the methods described in Chapter 1 (p. 20). HindIII and SmaI in vitro restriction
digests were performed by mixing 17.3 μL of plasmid DNA with 2 μL of buffer (Buffer J
for SmaI, or buffer B for HindIII) (Promega, Madison, WI), 0.2 μL BSA (Promega), and
0.5 μL of either HindIII or SmaI restriction enzyme (Promega). Tubes were vortexed,
briefly centrifuged, and incubated at 37°C (HindIII) or room temperature (SmaI) for 1 hr.
Enzymes were inactivated at 70°C for 30 min. An agarose gel was prepared and loaded
using the methods described in Chapter 1 to visualize the fragments and fragment sizes
were estimated using a lambda/HindIII digest as a size standard (Chapter 1 Methods, p.
19).
Plasmid DNA sequencing. Plasmid DNA was extracted, prepared, and
sequenced on the Illumina MiniSeq and the Oxford Nanopore MinION sequencers. For
Illumina sequencing, plasmids were extracted from electrotransformants using the normal
plasmid extraction protocol and were prepared for sequencing using Plasmid-Safe,
EcoRI, and Nextera XT DNA Library Prep Kit (Chapter 1, pp. 18-25).
For ONT sequencing, plasmids were extracted from electrotransformants using
the scaled-up plasmid extraction protocol and were prepared for sequencing using
Plasmid-Safe, Sau3AI, and 1D Ligation Sequencing Kit (Chapter 1, pp. 2-30).
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Sequence data processing. Sequence data was analyzed through a custom
bioinformatics analysis pipeline (Figure 13, Table 5).
Table 5. Analysis software used.
Name of
Version
Authors and/or
Software
Used
Reference

Link

Local Run
Manager and
GenerateFASTQ

1.3.1
and
1.0.0

Illumina

support.illumina.com/sequencing/
sequencing_software/local-runmanager-forminiseq/downloads.html

FastQC

0.11.7

Andrews, 2010

bioinformatics.babraham.ac.uk/pr
ojects/download.html#fastqc

MultiQC

1.2

Ewels et al., 2016

multiqc.info/

NanoPlot

1.13.0

De Coster et al.,
2018

github.com/wdecoster/NanoPlot

Albacore

2.10.0

Oxford Nanopore
Technologies

community.nanoporetech.com/do
wnloads

Porechop

0.2.3

Wick et al., 2017

github.com/rrwick/porechop

Filtlong

0.2.0

Ryan Wick

github.com/rrwick/filtlong

Unicycler

0.4.4

Wick et al., 2017

github.com/rrwick/unicycler

QUAST

4.6.3

Mikheenko et al.,
2016

quast.sourceforge.net/quast

Bandage

0.8.1

Wick et al., 2015

github.com/rrwick/bandage

Geneious

R8.1

Kearse et al., 2012

www.geneious.com/download/

BWA

0.7.10

Li, 2013

bio-bwa.sourceforge.net/

Minimap2

2.10

Li, 2018

github.com/lh3/minimap2

Samtools

1.7

Li et al., 2009

samtools.sourceforge.net/

Tablet

1.17.08.
17

Milne et al., 2017

ics.hutton.ac.uk/tablet/downloadtablet/

Prokka

1.13

Seemann, 2014

github.com/tseemann/prokka

ABRicate

0.8

Torsten Seemann

github.com/tseemann/abricate

BLAST

2.8.0

Altschul et al., 1990

blast.ncbi.nlm.nih.gov/Blast.cgi
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Table 5. (cont.)
PlasmidFinder

1.3

Carattoli et al.,
2014

cge.cbs.dtu.dk/services/PlasmidFin
der/

Integron_Finder

1.5.1

Cury et al., 2016

github.com/gempasteur/Integron_Finder

EasyFig

2.2.2

Sullivan et al.,
2011

mjsull.github.io/Easyfig/

To generate fastq files, Illumina reads were basecalled, de-multiplexed, and
adapters and barcode sequences were removed following the sequencing run. These
processes were carried out automatically by the Local Run Manager v. 1.3.1 software on
the Illumina MiniSeq sequencer (Illumina, San Diego, CA), using the analysis module
Generate FASTQ v. 1.0.0.

Figure 13. Bioinformatics analysis pipeline. MiniSeq image provided courtesy of
Illumina, LLC and MinION image provided courtesy of Oxford Nanopore Technologies.
ONT reads were basecalled and de-multiplexed using Albacore v. 2.10.0 (Oxford
Nanopore Technologies official basecalling software,
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https://community.nanoporetech.com/downloads). However, the threshold for identifying
barcode sequences within the reads is low (60% identity) and the probability of barcode
misidentification is high. To prevent barcode misidentification, Porechop v. 0.2.3 (Wick
et al., 2017) was used to de-multiplex the reads using a stricter threshold (75% identity)
and also to trim the barcode adapter sequences from the reads. Due to the relatively high
error rate of ONT data, 10% of the ONT reads with the lowest quality scores were
filtered using the Illumina reads as a reference (k-mer based quality filtering) using
Filtlong v. 0.2.0 (https://github.com/rrwick/filtlong).
The quality of the Illumina reads was assessed using FastQC v. 0.11.7 as well as
MultiQC v. 1.2 for generating quality score distribution plots (Andrews, 2010; Ewels et
al., 2016). NanoPlot v. 1.13.0 was used for assessing general sequencing run statistics
and for creating figures displaying the quality and read length distributions of the ONT
reads (De Coster et al., 2018).
Despite our attempt to remove the expected E. coli chromosomal DNA from the
plasmid DNA samples prior to sequencing, some chromosomal DNA was sequenced
along with the plasmids. BWA and Samtools (Li, 2013; Li et al., 2009) were used to
align the reads to the reference genome of the EC100 cells (E. coli K-12 DH10β,
complete genome, accession: CP000948.1) with the intent to use only the non-aligning
reads for assembly. This approach did not aid in assembling the plasmid genomes, as we
discovered shared regions of sequence between the E. coli chromosome and two of the
plasmids, pCCP1 and pCCP2. Thus we opted not to filter the reads prior to assembly.
Plasmid genome assembly. Plasmid genomes were assembled de novo using
Unicycler v. 0.4.4 (Wick et al., 2017). Unicycler was chosen for assembly because it
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accepts both Illumina and ONT reads and was designed for assembling bacterial genomes
and plasmids in a hybrid manner - taking advantage of the accuracy of the short reads and
the length of the (less accurate) long reads (Wick et al., 2017). The de-multiplexed
Illumina reads and the de-multiplexed, filtered ONT reads were used to generate hybrid
assemblies (Figure 13). The “--contamination” flag in Unicycler was used to supply the
E. coli K12 DH10β reference genome in order to filter out any contaminating ONT reads.
When the contamination flag is used, Unicycler will align ONT reads against the supplied
reference genome, and will discard any reads that align to the reference better than the
intermediate (short-read-only) assembly produced by Unicycler. Assembly graphs (gfa
files) were visualized in Bandage v. 0.8.1 (Wick et al., 2015) and evaluated using
QUAST v. 4.6.3 (Mikheenko et al., 2016).
Following the assembly, contigs were aligned to the E. coli K12 DH10β reference
genome (accession: CP000948.1, minimum alignment length 200bp, e-value < 1e-6) using
the BLAST search function that is integrated into the Bandage application. Any contigs
that aligned to the reference, or were smaller than 1000 bp were removed, leaving only
the circular contigs that were presumed to be the assembled plasmid genomes.
In silico and in vitro restriction digests. Restriction digests were performed on
each of the plasmids in vitro and in silico. The following restriction enzymes were used:
EcoRI (restriction site - GAATTC), HindIII (restriction site - AAGCTT), and SmaI
(restriction site - CCCGGG) and the DNA fragment patterns (number and molecular
weight of fragments) seen on a gel were compared with those generated in silico.
In silico restriction digests were performed in Geneious v. R8.1 (Biomatters,
Auckland, New Zealand) by uploading the assembled genome (in fasta format) to the
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software (Kearse et al., 2012). Restriction sites for all three enzymes mentioned above
were identified within the plasmid genomes and the number and size (in bp) of the
predicted fragments for each digest were calculated.
Read alignment. To determine the average depth of coverage, reads were aligned
to their respective assemblies using BWA v. 0.7.10 (BWA-MEM, specifically) for the
Illumina reads and Minimap2 v. 2.10 for the ONT reads (Li, 2013; Li, 2018). These two
aligners were chosen because BWA-MEM was originally designed for highly accurate
short reads ranging from 75-300 bp while Minimap2 was designed for error-prone long
reads (greater than 300 bp), produced by either ONT or PacBio single molecule
sequencers.
After alignment files (SAM format) were generated with either BWA or
Minimap2, SAM files were converted to BAM files using SAMtools v. 1.7 with the
SAMtools command “view” (Li et al., 2009). SAMtools command “sort” was used to
sort the BAM files, specifically sorting the aligned reads within the BAM file based on
their position in reference genome (sorted from first to last base in the assembly).
SAMtools command “flagstat” was used to generate statistics on alignments and
SAMtools command “index” was used to generate index files that are necessary for
viewing alignments in Tablet. Tablet v. 1.17.08.17 was used to visualize the alignment
BAM files (Milne et al., 2017).
Annotation. The plasmid genome assemblies were annotated automatically using
Prokka v. 1.13 (Seemann, 2014) and then curated manually. ABRicate v. 0.8 (Seemann,
github.com/tseemmann/abricate/) was used with the ARG-ANNOT database of antibiotic
resistance genes to screen the assemblies for antibiotic resistance genes not identified by
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Prokka. PlasmidFinder v. 1.3 (Carattoli et al., 2014) was used to identify replication
sequences present in the assemblies to identify the incompatibility group that each
plasmid belongs to. Integron_Finder v. 1.5.1 was used to identify integrons as well as
CALIN elements (Cluster of attC sites Lacking Integrase Nearby) (Cury et al., 2016).
The INTEGRALL database, which contains over 9000 entries for a variety of integrons,
integrases, and gene cassettes, was queried to confirm Integron_Finder’s results and to
identify additional integron-related sequences for each of the plasmids (Moura et al.,
2009). Lastly, the amino acid sequences of the remaining coding sequences (also CDS)
identified by Prokka as “hypothetical protein” were aligned to the non-redundant (nr)
GenBank database using BLASTp (Altschul et al., 1990). CDS were annotated when an
alignment occurred to a known protein with a minimum % identity of 87%, >92% query
coverage, and e-value < 1e-6.
Easyfig v. 2.2.2 was used to perform pairwise alignments and compare parts or
whole genomes to one another (Sullivan et al., 2011). Geneious v. R8.1 was used to
create plasmid genome maps (Kearse et al., 2012).

68
Results and Discussion
Exogenous plasmid capture. Transmissible tetR plasmids were isolated from
stream sediment using an exogenous plasmid capture method that does not require the
cultivation of donor cells. Cells were released from stream sediment samples from each
of the sampling sites and combined with the rifR recipient strain, LA61. During each
capture attempt, positive and negative controls were used to verify conjugation.
Eleven captures were performed from February 2016 to April 2017 and four of
the eleven captures yielded a total of 77 transconjugants exhibiting resistance to
tetracycline (Table 6). No transconjugants were yielded from either Muddy Creek, War
Branch, or Pleasant Run sites in all of the captures that were performed.
Table 6. Summary of exogenous plasmid capture results.
Number of transconjugant
Date of capture
colonies

Site

July 2016

2

Cooks Creek Park

September 2016

2

Cooks Creek Park

October 2016

6

Cooks Creek Rt. 11

77

69 from Cooks Creek
Rt. 704
8 from Cooks Creek
Park

February 2017

Three plasmids were selected for further investigation: pCCP1 and pCCP2 which
were both captured in July 2016 from Cooks Creek Park, and pCCRT11-6 which was
captured in October 2016 from Cooks Creek at Route 11. In addition, one plasmid
conferring multi-drug antibiotic resistance, pEG1-06, was investigated in this study. It
was captured previously in October of 2006 from Shull’s Run in Rockingham County,

69
Virginia (Gehr, 2013) using the same exogenous plasmid capture protocol and using the
same recipient strain, LA61.
Verification of LA61 transconjugants. Putative transconjugants were verified as
LA61 (harboring a tetracycline resistance plasmid) through plating on media amended
with both rifampicin and tetracycline. Transconjugants were also cultivated on Eosin
Methylene Blue plates and after 24 hrs incubation, dark purple colonies with a metallic
green sheen were observed – typical of E. coli - which was also observed with the LA61
plasmid-free recipient. A PCR-based DNA fingerprinting method was used to confirm
transconjugants were LA61. The BOX rep-PCR amplifies intervening regions from 154
bp BOX sequences that are interspersed throughout many prokaryotic genomes in strainspecific locations (Rademaker et al., 1998). Each transconjugant and LA61 were also
subjected to BOX rep-PCR and the banding patterns were identical (Figure 14).
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Figure 14. Example of BOX rep-PCR fingerprint analysis of transconjugants. Lane 1:
LA61, lane 2: transconjugant from Cooks Creek Rt. 704, lane 3: transconjugant from
Cooks Creek park, lane 4: LA61, lane 5: LA61, lane 6: transconjugant from Cooks Creek
Rt. 704, lane 7: transconjugant from Cooks Creek Rt. 704, lane L: GeneRuler 1 kb Plus
DNA ladder (ThermoFisher).
Antibiotic susceptibility phenotyping. Plasmids were extracted from
transconjugants and electroporated into the plasmid-free, tetracycline sensitive, and
electrocompetent E. coli strain EC100. Tetracycline resistance of electrotransformants
was verified by plating on a TSA plate amended with tetracycline. These were
subsequently tested for resistance to 11 additional antibiotics using a modified Stokes
antibiotic disc diffusion assay (Table 7, Figure 12). pEG1-06 conferred resistance to
tetracycline, ticarcillin, piperacillin, and piperacillin/tazobactam. The pEG1-06 plasmid
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also conferred decreased susceptibility to cefepime; however the resistance breakpoint of
3 mm reduction of the zone of inhibition relative to the plasmid-free EC100 strain was
not surpassed (exhibited a 2 mm reduction). Plasmids pCCP1, pCCP2, and pCCRT11-6
each conferred only tetracycline resistance.
Table 7. Antibiotic resistance phenotypes of four tetR plasmids, electrotransformed into
E. coli strain EC100.
Plasmid
Resistance Phenotypea
TE, TIC, PIP, TZP, FEPb
pEG1-06
TE
pCCP1
TE
pCCP2
TE
pCCRT11-6
a

Tetracycline (TE), ticarcillin (TIC), piperacillin/ tazobactam (TZP), piperacillin (PIP), and cefepime
(FEP).
b
Susceptibility was decreased, but did not surpass the resistance breakpoint of a reduction in 3 mm in the
zone of inhibition

Plasmid DNA sequencing. Plasmid DNA was extracted, prepared, and
sequenced on the Illumina MiniSeq and the Oxford Nanopore MinION sequencers. For
Illumina sequencing, plasmids were extracted from electrotransformants using the normal
plasmid extraction protocol and were prepared for sequencing using Plasmid-Safe,
EcoRI, and Nextera XT DNA Library Prep Kit (Chapter 1 Methods pp. 5-12). For ONT
sequencing, plasmids were extracted from electrotransformants using the scaled-up
plasmid extraction protocol and were prepared for sequencing using Plasmid-Safe,
Sau3AI, and 1D Ligation Sequencing Kit (Chapter 1 Methods pp. 2-17).
Plasmid genome assembly. After de-multiplexing and barcode trimming, the
ONT reads were filtered using Filtlong to remove the 10% of reads that had the lowest
quality scores. These quality scores are arbitrary k-mer matching quality scores set by
Filtlong and are not to be confused with Phred Q scores.
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Unicycler is a de novo hybrid assembly pipeline designed for bacterial genomes
that assembles short reads into an accurate and connected De Bruijn assembly graph
using SPAdes followed by simplification of the graph using both long and short reads
(Wick et al., 2017). Unicycler was first used to assemble the plasmid genomes using the
short reads only (SRO). This resulted in assemblies with a large number of contigs for
each plasmid, ranging from 11 contigs for pEG1-06 up to 947 contigs for pCCP1 with
varying degrees of connectivity (Table 8, Figure 15A, 14D, 14G, 14J). In addition to the
expected contaminating E. coli chromosomal contigs present in each of the assemblies,
we expected each assembly to result in one contig (connected with no dead ends) of
much greater sequencing depth that we presumed would belong to the plasmid genome.
In the SRO assemblies for each plasmid, contigs connected into roughly circular
structures that had no dead ends (at a higher depth); however they consisted of three or
more inter-connected contigs, and could not be resolved into a single circular contig,
likely due to repeated sequences that were larger than the length of the Illumina reads
(max 151 bp reads length) (Figure 15A, 14D, 14G, 14J). Difficulty in resolving plasmid
structures from whole-genome sequence data, especially large (> 50kb) plasmids with
repeated sequences, is a long-standing issue that can theoretically be solved with the
addition of long sequence reads, even those with low (< 10X) depth of coverage
(Arredondo-Alonso et al., 2017; Wick et al., 2017).
Unicycler was used to assemble the plasmid genomes using both the Illumina
reads and the ONT reads. The hybrid assembly of each plasmid had fewer, larger contigs
with less dead ends than the SRO assemblies, however many small (<1000 bp), linear
contigs with dead ends were present (Table 8, Figure 15B, 14E, 14H, 14K). These small,
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linear contigs likely were assembled from the contaminating E. coli reads or were
assembly errors arising from the plasmid reads.
Following assembly of the plasmid genomes, contiguous sequences (contigs)
smaller than 1000 bp and contigs that aligned to the E. coli reference genome (E. coli str.
K12 substr. DH10β [same strain as EC100], accession: CP000948.1) were removed.
Assemblies were evaluated using QUAST (Table 8) and assembly graphs were visualized
using Bandage (Figure 15) (Mikheenko et al., 2016; Wick et al., 2015).
Table 8. Assembly metrics for four plasmids assembled using only short reads (SRO)
and short plus long reads (Hybrid). QUAST was used to determine these assembly
statistics.
Plasmid

Assembly
type

# of
contigs

# of
contigs
≥ 1000
bp

Largest
contig
(bp)

Total length of
assembly (bp)

%GC

N50a
(bp)

pCCP1

SRO

947

891

78,847

3,938,113

51.16%

6,060

pCCP1

hybrid

1

1

59,842

59,842

57.04%

59,842

pCCP2

SRO

217

181

140,875

4,415,838

50.83%

44,771

pCCP2

Hybrid

1

1

59,842

59,842

57.09%

59,842

pCCRT11-6

SRO

894

736

106,131

1,535,433

51.79%

1,724

pCCRT11-6

Hybrid

1

1

121,469

121,469

48.89%

121,469

pEG1-06

SRO

11

9

60,245

84,141

60.96%

60,245

pEG1-06

Hybrid

1

1

71,416

71,416

62.74%

71,416

A

N50 is the contig length (in bp) that 50% of the assembly is contained in contigs that are greater than or
equal to the length of N50
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Figure 15. Short read only assembly graphs (SRO), hybrid assembly graphs, and hybrid
assembly graphs after contigs < 1000 bp or those that aligned to E. coli were removed for
plasmids pCCP1 (A, B, C), pCCP2 (D, E, F), pCCRT11-6 (G, H, I), pEG1-06 (J, K, L).
Node (contig) colors are random and between different assembly graphs, contig sizes are
not drawn to scale. Assembly graph files (gfa) were generated using Unicycler (Wick et
al., 2017) and visualized using Bandage (Wick et al., 2015).
Hybrid assembly of pCCRT11-6 after removing contigs < 1000 bp or those that
aligned to E. coli resulted in a single, circular contig that was 121,469 bp in length and
had 48.89% GC content (Figure 15I, Table 8). Assembly of pCCP1 resulted in a single,
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circular contig that was 59,842 bp in length and had 57.04% GC content (Figure 15C,
Table 8). Assembly of pCCP2 resulted in a single, circular contig that was 59,842 bp in
length and had 57.09% GC content (Figure 15F, Table 8). Assembly of pEG1-06 resulted
in a single, circular contig that was 71,416 bp in length and had 62.74% GC content
(Figure 15L, Table 8).
In silico and in vitro restriction digests. Assembly errors oftentimes arise in
plasmid genomes due to large duplications or repeats because these regions cannot be
resolved by short read sequencing alone (Smalla et al., 2015). To help verify that the
plasmid genomes were correctly assembled, both in vitro and in silico restriction digests
were performed on each of the plasmids. Each plasmid was digested in vitro with EcoRI,
SmaI, and HindIII and visualized on a gel. In silico digests were performed using
Geneious software to determine the predicted number of fragments and their respective
sizes in bp. The number and size of the resulting plasmid DNA fragments were compared
between both types of “digest”.
For pCCP1 digested by EcoRI, 15 out of 16 in silico predicted fragments were
visible on a gel (Figure 16). The smallest fragment, predicted to be 369 bp in length, was
not observed. For pCCP1 digested by HindIII, 6 out of 6 in silico predicted fragments
were observed and for pCCP1 digested by SmaI, 13 out of 16 predicted fragments were
observed (Figure S19). The 3 fragments not observed were predicted to be 766, 40, and
40 bp in size.
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Figure 16. Example of in silico and in vitro restriction digestion of pCCP1 with EcoRI.
In silico digest fragment number and sizes were determined using Geneious. Lane 1:
pCCP1 treated with RNAse A, plasmid-safe, and EcoRI, lane 2: same sample as lane 1
with AMPure XP bead purification and concentration, lane L: lambda/HindIII digest.
For pCCP2 digested by EcoRI, 9 out of 14 fragments were observed and the
fragments not observed were predicted to be 1,344, 845, 686, 619, and 319 bp in length
(Figure S19). For pCCP2 digested by HindIII, 6 out of 6 fragments were observed and for
pCCP2 digested by SmaI, 13 out of 16 predicted fragments were observed (Figure S19).
The 3 fragments not observed were predicted to be 766, 40, and 40 bp in size.
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For pCCRT11-6 digested by EcoRI, 6 out of 8 fragments were observed and the
fragments not observed were predicted to be 600 and 284 bp in length (Figure S16). For
pCCRT11-6 digested by HindIII, 1 fragment was predicted and observed (Figure S17).
For pCCRT11-6 digested by SmaI, 2 out of 3 fragments were observed and the fragment
not observed was predicted to be 766 bp in length (Figure S18).
For pEG1-06 digested by EcoRI, 6 out of 6 fragments were observed (Figure S13)
and for pEG1-06 digested by HindIII, 5 out of 9 predicted fragments were observed
(figure S14). The 4 fragments not observed were predicted to be 717, 159, 159, and 59 bp
in size. For pEG1-06 digested by SmaI, 3 out of 3 predicted fragments were observed
(Figure S15).
All of the predicted fragments that were not observed within the agarose gels
were ≤ 1,344 bp in size and were likely not seen for three reasons: (1) these fragments
were too small (e.g. 40 bp), and ran off the gel due to the long gel running time (90 min
or longer in some gels); (2) the DNA concentrations of these fragments were too low,
thus were too faint to be seen on the gel; or (3) these fragments did appear on the gel, but
were masked by a light colored patch near the 564 bp marker that was caused by the
loading dye that was mixed with all samples prior to loading the gels (Figure S19).
Read alignment to assembled genomes. Reads for each plasmid were aligned to
their respective assemblies using BWA (Li, 2013) for the Illumina reads and Minimap2
(Li, 2018) for the ONT reads. Alignment statistics were determined using Samtools (Li et
al., 2009) and Tablet (Milne et al., 2017). For all 4 plasmids, 100% of the assemblies
were covered by both types of reads (Table 7). Visualizations of pEG1-06 Illumina reads
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aligned to its assembly and of pCCP2 ONT reads aligned to its assembly can be found in
the supplementary materials (Figure S11 and S12).
Table 9. Read alignment statistics of the Illumina and ONT reads aligned to each of the
four plasmid genome assemblies. Average coverage depth, max coverage depth and % of
assembly covered were determined using Tablet and % of reads aligned to assembly was
determined using Samtools.
Illumina reads
Max
Average
% of reads
% of
Genome
coverage
Plasmid
coverage
aligned to
assembly
size
depth
depth (X)
assembly
covered
(X)
pEG1-06
71,416 bp
4,373.1
8,333
98.95
100
pCCRT11-6
121,469 bp
1,847.1
4,730
93.85
100
pCCP1
58,942 bp
1,929.8
4,552
76.62
100
pCCP2
58,942 bp
1,626.5
5,107
50.2
100
ONT reads
pEG1-06
71,416 bp
2,469.9
2,691
89.08
100
pCCRT11-6
121,469 bp
530.6
697
77.08
100
pCCP1
58,942 bp
105.8
178
24.8
100
pCCP2
58,942 bp
114.7
194
42.4
100

Average depths of coverage for both types of reads aligned to each of the
assemblies were high. This was expected due to the relatively small size of the plasmid
genomes and the small number of samples that were multiplexed and sequenced in each
of the sequencing runs. Accurate de novo draft assemblies can typically be achieved with
anywhere from 50 - 100X coverage of bacterial genomes (Desai et al., 2013). 24.8% of
ONT reads from pCCP1 aligned to the assembly, which was much lower than the three
other plasmids and their respective ONT read alignments. This sample had a high
percentage of reads belonging to the E. coli chromosome, as confirmed by BLAST
alignments performed in bandage and the filtering performed after hybrid assembly
(Figure 15B).
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Plasmid genome annotation. Plasmid genome assemblies were annotated using
Prokka, which is a tool designed for rapidly annotating bacterial genomes by predicting
coding sequences, translating predicted CDS into amino acid sequences, and comparing
the amino acid sequences to databases of known proteins using BLAST (Seemann, 2014).
CDS that align to a protein with an e-value < 10-6 were annotated as the reference (i.e. the
protein from the database that the CDS aligned to) and CDS with no alignments < 10-6
were annotated as “hypothetical protein.” Then the plasmid genomes were screened for
antibiotic resistance genes using ABRicate with the ARG-ANNOT database (Antibiotic
Resistance Gene-ANNOTation) and screened for integrons and integron-related
sequences using Integron_Finder and the INTEGRALL database. Lastly, the amino acid
sequences of CDS that were labeled as “hypothetical protein” were aligned to the nr
database using BLASTp. These data are summarized in Table 8.
Table 10. Summary of isolation sources, sizes, CDS, incompatibility groups, and
resistance genes of the four tetracycline resistance plasmids.
Plasmid

Sediment
Sample
source

Size
(bp)

#
Annotated
CDS

# CDS
classified as
“hypothetical
protein”

Inc
group

Resistance
genes

pEG1-06

Shulls
Run

71,416

74

7

P-1β

tetG, tetC,
tetR, strB,
folP, pse-1,
emrE, ant1,
ydhC

pCCRT11-6

Cooks
Creek at
Rt. 11

121,469

54

83

A/C2

tetA, tetR,
bcr, strB,
yedA
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Table 10. (cont.)

pCCP1

Cooks
Creek
Park

58,942

71

34

P-9

tetR, tetA,
yedA

pCCP2

Cooks
Creek
Park

58,942

71

35

P-9

tetR, tetA,
yedA

Plasmid pEG1-06. The 71,416 bp pEG1-06 genome is comprised of 81 CDS, of
which 74 were successfully annotated, and 7 were designated as “hypothetical proteins”
(Figure 17, Table S1). The replicon trfA (plasmid replication initiator protein) was
identified by Prokka and confirmed by PlasmidFinder as an IncP-1β replicon that aligned
with 99.14% identity and 100% coverage to IncP-1β plasmid R751 from an Enterobacter
aerogenes isolate (accession U67194.4, Thorsted et al., 1985). The pEG1-06 genome also
shared a high degree of similarity with pEG1-1 (99.99% identity, 96.7% coverage),
which was captured at the same time as pEG1-06 (Gehr, 2013), sequenced, and identified
as an IncP-1β plasmid (Libuit, 2016).
The pEG1-06 genome includes 8 functional modules: replication, stability,
accessory module 1 (AM1), replication, mate pair formation (Mpf), accessory module 2
(AM2), DNA transfer region (Dtr), and stability (Figure 17). pEG1-06 is likely a selftransmissible (i.e. conjugative) plasmid due to its initial conjugation during capture
(Gehr, 2013) and the presence of both Mpf and the Dtr modules that are found in all
IncP-1β plasmids (Adamczyk and Jagura-Burdzy, 2003). The ~14 kb Mpf module
consists of the genes trbB/C/D/E/F/G/H/I/J/K/L/M/N/O/P and ompX; these genes code for
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proteins that make up the type IV secretion system used during conjugation (Smillie et
al., 2010). The ~15 kb Dtr module consists of the genes traC/D/E/F/G/I/J/K/L/M/N/O
which are known to be involved in relaxosome formation and the initiation of rolling
circle replication necessary for conjugal DNA transfer (Adamczyk and Jagura-Burdzy,
2003).

Figure 17. Functional modules and CDS mapped to the pEG1-06 genome assembly.
Coding sequences and annotations are on the outer circle and the arrows point in the
direction of transcription (outermost CDS are on complementary strand and the inner
CDS are on the template strand): CDS annotated by Prokka and confirmed by BLASTp
search (gold), antibiotic resistance genes annotated with ABRicate (red), Integron_finder
annotations (cyan), and CDS annotated by Prokka as “hypothetical protein” (grey).
Plasmid functional modules labeled on the inner circle: Accessory Modules (AM) (red),
stability and partitioning regions (green), DNA transfer (Dtr) and mate pair formation
(Mpf) regions (blue), and replication regions (yellow). Inner blue trace represents % GC.
Another defining feature of IncP-1β plasmids is that the Mpf and Dtr modules are
often separated by clusters of restriction sites, allowing for the integration of accessory
modules that are non-essential to the plasmid genome (Adamczyk and Jagura-Burdzy,

82
2003). Between the Dtr and Mpf modules, the pEG1-06 genome contains a complete
class 1 integron identified by Integron_Finder (Figure 18). The ~17 kb integron consists
of intI integrase (tyrosine recombinase) and its promotor Pint_1, gene cassette promotor
Pc_1, integrase attachment site attI, a hypothetical protein, and two gene cassettes. The
first cassette contains a recombination site attC and ant1, which encodes an
aminoglycoside resistance protein, streptomycin 3”-adenylytransferase. The second
cassette contains a recombination site attC and emrE, which encodes a multi-drug
transporter protein. This class 1 integron contains the three key components which
classify it as a complete integron: (1) an intI gene encoding for an integrase that controls
the integration and excision of gene cassettes, (2) an attI site, and (3) a gene cassette
promotor (Pc) that drives the expression of the cassettes (Schlüter et al., 2007).

Figure 18. Class 1 integron located in accessory module 2 of the pEG1-06 genome. The
integrase intI and its promotor are positioned below the other annotations to indicate
transcriptional direction to the left, and the annotations above are positioned to indicate
transcriptional direction to the right. Predicted CDS for ant1_1, aminoglycoside
resistance gene, and emrE, multidrug transporter gene, were confirmed by Prokka.

83
A CALIN element (Cluster of attC sites Lacking Integrase Nearby) was also
identified by Integron_Finder that is ~8 kb downstream of the class 1 integron, beginning
with β-lactamase gene pse-1 (914 bp), attC (110 bp), aminoglycoside resistance gene
ant1 (809 bp), attC (59 bp), and multidrug transporter gene emrE (347 bp). The % GC of
the CALIN element and the class 1 integron have obvious derivations from the mean %
GC of the entire pEG1-06 genome and suggests that these regions of the genome were
acquired in recent evolutionary history by horizontal gene transfer (Figure 17).
In addition to the insertion site between the Mpf and Dtr modules another classic
insertion site in IncP-1β plasmid genomes occurs between the origin of vegetative
replication (oriV - likely located directly upstream of repA in pEG1-06) and trfA, which
splits the set of replication genes into two parts (Dennis, 2005). IncP-1β plasmids are
known to incorporate additional genes in these specific locations because they do not
disrupt any of the essential backbone gene functions. Thus, insertions are common
because they likely do not produce significant deleterious effects. The accessory module
1 present in pEG1-06 may have been incorporated by a transposon, due to the separation
of repA and trfA plasmid replication genes and the presence of the transposon-related
genes, Tn3 transposase, transposase (IS605), and a gene encoding a putative DNA
resolvase (Figure 17).
pEG1-06 resistance phenotype and genotype. Plasmid pEG1-06 conferred
resistance to tetracycline, piperacillin, ticarcillin, piperacillin/tazobactam and conferred
decreased susceptibility to cefepime (Table 7). These phenotypes are likely due to the
presence of multiple antibiotic resistance genes located throughout the genome including
the tetracycline resistance genes tetC, tetR (repressor), tetG and the β-lactamase gene pse-
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1 for resistance to piperacillin, ticarcillin, and piperacillin/tazobactam as well as pse-1 for
decreased susceptibility to cefepime.
Surprisingly, pEG1-06 did not confer resistance to
trimethoprim/sulfamethoxazole despite the presence of 2 copies of sulfonamide
resistance gene folP (also known as sul1), suggesting these genes may be non-functional.
Additional antibiotic and toxin resistance genes located within the genome that were not
tested phenotypically were the streptomycin/spectinomycin resistance gene strB, two
copies of the streptomycin/spectinomycin resistance gene ant1, the florfenicol resistance
gene ydhC (also known as floR), and the multi-drug transporter gene emrE, which is
known to confer resistance to toxic compounds such as methyl viologen, ethidium
bromide, acriflavine, tetraphenylphosphonium, and benzalkonium (Yerushalmi et al.,
1995).
pEG1-06 stability modules. The modules designated as “stability” (~8kb and 0.5
kb, respectively) contain essential backbone genes with predicted functions including the
plasmid partitioning genes parB/A; the plasmid maintenance and stability genes krfA,
trfB, kleF/E/B/A, korC, klcB/A, nikR (type II TA system parD family antitoxin); and the
relE/parE family toxin gene. A second pair of toxin antitoxin (TA) genes were identified,
the mazF/E Type II TA system. These are genes involved with post-segregational killing
or so-called plasmid-addiction systems and are common to large, conjugative plasmids
(Schlüter et al., 2015). Toxin mazF encodes an endoribonuclease that targets RNAs
produced in the cell, and mazE encodes an antitoxin that binds to and degrades the mazF
toxin (Kamada et al., 2003). If a daughter cell does not inherit a plasmid copy following
cell division, it will not be able to produce the antitoxin protein, thus killing plasmid-free
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daughter cells. The nikR (parD) and parE genes are known to be type II antitoxin and
toxin genes respectively, where parD antitoxin either inhibits the toxin itself or inhibits
the synthesis of the toxin (or potentially both) and the parE toxin inactivates DNAgyrase, thus inhibiting DNA replication leading to cell death (Schlüter et al., 2007).
An interesting characteristic that was observed with pEG1-06 was that when the
plasmid DNA was extracted from EC100 cells, the cells containing pEG1-06 routinely
yielded significantly more plasmid DNA than the three other plasmids investigated in this
study. When pEG1-06 DNA was visualized in agarose gels, regardless whether
undigested plasmid or digested plasmid samples were visualized on an agarose gel,
pEG1-06 always produced the brightest bands and routinely yielded higher DNA
concentrations when measured using the Qubit fluorimeter. We hypothesize that this may
be caused by the presence of the two different types of TA systems present within the
pEG1-06 genome in addition to the various genes related to stable inheritance (kfrA),
active partitioning (korA, parB/A), and efficient modulation of partitioning (kleF/E/B/A,
klcB/A) (Schluter et al., 2007).
Plasmid pCCRT11-6. The 121,469 bp pCCRT11-6 genome is comprised of 137
CDS of which 54 were successfully annotated and 83 were designated as “hypothetical
proteins” (Figure 19, Table S2). The CDS for the replicon repA was identified by
PlasmidFinder as repA with the closest match from the IncA/C2 plasmid pNDM-KN
originally isolated from Klebsiella pneumoniae strain Kp7 (accession JN157804,
Caratolli et al., 2012). The repA genes aligned with 92.27% identity and 100% coverage.
The entire pCCRT11-6 genome is most similar to the 173 kb, IncA/C2, type 1 plasmid
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R16a originally isolated from Providencia stuartii and aligned with 87% identity and
74% coverage of the pCCRT11-6 genome (Szabo et al., 2016).

Figure 19. Functional modules and CDS mapped to the pCCRT11-6 genome assembly.
Coding sequences and annotations are on the outer circle (outermost CDS are on
complementary strand and the inner CDS are on the template strand): CDS annotated by
Prokka and confirmed by BLASTp search (gold), antibiotic resistance genes annotated
with ABRicate (red), and CDS annotated by Prokka as “hypothetical protein” (grey).
Plasmid functional modules labeled on the inner circle: Accessory Module (AM1) (red),
stability and partitioning regions (orange), conjugative transfer regions (Tra1/2) (blue),
and replication regions (yellow). Inner blue trace represents % GC. pCCRT11-6 has a
48.89 % mean GC content.
The pCCRT11-6 genome includes 6 functional modules: replication, partitioning,
accessory module 1 (AM1), 2 conjugative transfer (Tra) modules, and a stability module
(Figure 19). pCCRT11-6 is likely a self-transmissible plasmid due to its ability to be
conjugated into LA61 and the presence of the Tra modules that are typical in IncA/C2
plasmids (Harmer and Hall, 2015). Both Tra modules contain genes that are involved in
the type IV secretion system required for conjugation. The Tra1 module is a ~30 kb
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region that consists of the genes topB, traI/D/L/E/B/K/A/V, dsbC, traC, trhF, traW, pdeR,
and traU/N. The Tra2 module is a ~12 kb region that consists of the genes tus, hns, addA,
traF/H/G, permease, and ner. IncA/C2 conjugative transfer proteins have not been
characterized experimentally; however the genes do share a high degree of similarity with
related conjugative transfer genes from plasmids of other incompatibility groups such as
certain IncF plasmids (Hammer and Hall, 2015). The Tra genes present on pCCRT11-6
align with a high degree of similarity (>82% nucleotide identity) to that of plasmid R16a
and share nearly identical gene synteny (Figure 20a and 20b).
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Figure 20. Comparison of the two conjugative transfer (Tra) modules of pCCRT11-6
with those of plasmid R16a. (A) The ~30 kb Tra1 region and (B) the ~12kb Tra2 region
aligned to that of plasmid R16a. Orange arrows represent CDS and they point in the
direction of transcription. CDS without labels are “hypothetical proteins.” Alignment
percent identity is shown by the key in the bottom right corner, with darker shades
indicating a higher percent identity.
All IncA/C2 plasmids have essential backbone genes involved in replication,
maintenance, and stability (including plasmid partitioning), conjugative transfer, protein
folding, and restriction/modification (Frick et al., 2009). pCCRT11-6 contains all of the
essential backbone genes including repA (replication initiation protein A), tus (DNA
replication terminus site-binding protein), parA/B (plasmid partitioning proteins), stbA
(essential for accurate partitioning of low-copy plasmids), conjugative transfer genes
present in tra1 and tra2 modules, hhaIM (cytosine-specifc DNA methylase), topB (DNA
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topoisomerase III), primase/helicase and addA (DNA primase/helicases), dsbA/C
(disulphide bond proteins for ensuring correct protein folding) (Fricke et al., 2009;
Harmer and Hall, 2015).
In E. coli, dsbA is known to encode a protein that forms disulphide bonds as
nascent peptides emerge into the cell’s periplasm and dsbC encodes a protein that
stabilizes disulphide bonds produced by dsbA (Harmer and Hall, 2015). Due to these
genes location in the IncA/C2 plasmid genomes, either upstream (dsbA) or within (dsbC)
conjugative transfer modules, they are thought to stabilize and ensure the correct folding
of the components of the Type IV secretion system used during conjugation (Harmer and
Hall, 2015). The dsbA/C genes are both present within pCCRT11-6 and likely aid in
successful conjugation and transfer of the plasmid into new hosts.
pCCRT11-6 resistance phenotype and genotype. Plasmid pCCRT11-6
conferred resistance to tetracycline (Table 7). This phenotype is likely due to the presence
of the tetracycline resistance genes tetA/R that are located within accessory module 1
(AM1, Figure 19). Accessory module 1 also shows a % GC content that is higher and is a
derivation from the mean 48.89% GC content, suggesting incorporation of this region by
horizontal gene transfer in recent evolutionary history (Figure 19). Additional antibiotic
and toxin resistance genes located within the genome, that were not tested
phenotypically, were the streptomycin/spectinomycin resistance gene strB, the florfenicol
resistance gene bcr (also known as floR), and the putative drug transporter gene yedA
(also known as eamA) which is known to confer resistance to the toxic compound
bromoacetate (Desai and Miller, 2010).
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IncA/C plasmids are associated with the spread of genes conferring resistance to
clinically relevant antibiotics such as carbapenems and third-generation cephalosporins
(Harmer and Hall, 2015) however no β-lactamase resistance genes were found in
pCCRT11-6. pCCRT11-6 does not have either anbiotic resistance island A (ARI-A) or
ARI-B that are typically located in IncA/C plasmids. ARI-B is typically located directly
upstream of the parA/B operon and contains antibiotic resistance genes, a class 1
integrons, and transposons however none were identified in that location in the
pCCRT11-6 genome (Harmer and Hall, 2015). ARI-A is typicaly located directly
upstream of the rhs1 and intI genes and
Plasmids pCCP1 and pCCP2. The 58,942 bp pCCP1 and pCCP2 genomes are
comprised of 71 CDS (34 labeled as “hypothetical protein”) and 72 CDS (35 labeled as
“hypothetical protein”), respectively (Tables S3, S4). The two plasmid genomes are
nearly identical to one another, with evidence of a rearrangement of transposase-related
CDS present in accessory module 1 (Figure 21).
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Figure 21. Comparison of pCCP1 and pCCP2 genomes. Orange arrows represent CDS
and they point in the direction of transcription. CDS labeled as “hypo.” or without labels
are “hypothetical proteins.” Alignment percent identity is shown by the key in the bottom
right corner, with darker shades indicating a higher percent identity.
Both plasmids belong to the incompatibility group IncP-9 due to their similarity to
the backbone regions (specifically the rep genes) of the IncP-9 plasmids pMT2 and
pWW0 (Figure 22 and 24A, respectively). Sections of pCCP1 and pCCP2 align to pMT2,
which is a ~10 kb plasmid that contains a cluster of replication and plasmid stability
genes cloned into a new plasmid vector that were originally from the 75 kb IncP-9
plasmid pM3 (Sevastsyanovich et al., 2005). The repA gene aligns with > 92% identity
to that of pMT2, as well as the adjacent genes, trbD/C, parA/B/R/C, DNA resolvase, and
an open reading frame (Figure 22).
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Figure 22. Comparison of the partitioning and replication regions of pCCP1 to the pMT2
plasmid. Orange arrows represent CDS and they point in the direction of transcription.
CDS labeled as “hypo.” or without labels are “hypothetical proteins.” Alignment percent
identity is shown by the key’s in the bottom right corner, with darker shades indicating a
higher percent identity.
The pCCP1 and pCCP2 genomes include 7 functional modules: replication,
accessory module 1 (AM1), stability, DNA transfer (Dtr), mate pair formation (Mpf), and
partitioning (Figure 23; pCCP2 map can be seen in supplemental materials Figure S20).
Both pCCP1 and pCCP2 are likely self-transmissible plasmids due to their ability to
transfer into LA61 and the presence of the Mpf and Dtr modules. The ~8.5 kb Mpf
module consists of the genes virB1/11/10/9/8, type VI secretion protein-encoding gene,
and virB5/4/3/2 that encode proteins that are required for the synthesis of the type IV
secretion system used during conjugation (Greated et al., 2002). The ~10.3 kb Dtr
module consists of the genes traD, traD (trwB), traI, pld, and putative nuclease that
encode proteins that are necessary for conjugal DNA transfer (Greated et al., 2002). Both
the Mpf and Dtr modules align with > 84% identity to that of pWW0 which is an IncP-9
archetype ~117 kb plasmid with a ~46kb backbone originally isolated from Pseudomonas
putida strain MT-2 (Figure 24b).
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Figure 23. Functional modules and CDS mapped to the pCCP1 genome assembly.
Coding sequences and annotations are on the outer circle (outermost CDS are on
complementary strand and the inner CDS are on the template strand): CDS annotated by
Prokka and confirmed by BLASTp search (gold), antibiotic resistance genes annotated
with ABRicate (red), and CDS annotated by Prokka as “hypothetical protein” (grey).
Plasmid functional modules labeled on the inner circle: Accessory Module (AM1) (red),
stability and partitioning regions (orange), DNA transfer (Dtr) and mate pair formation
(Mpf) regions (blue), and replication regions (yellow). Inner blue trace represents % GC.
pCCP1 has a 57.04% mean GC content.
pCCP1 and pCCP2 stability and partitioning modules. The ~2.1 kb
partitioning modules contain essential plasmid partitioning genes parA/B/R and an
adjacent hypothetical protein that aligned with > 92% identity to the parA/B/R/C genes of
pMT2 and with > 84% identity to the parA/B and korA genes of pWW0 (Figure 22 and
24b). The ~0.6 kb and ~2 kb stability modules contain a putative toxin-antitoxin system
of the RelE/ParE family as well as stdB (plasmid stabilization protein) and a putative zinc
metalloprotease.
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pCCP1 and pCCP2 accessory modules. Both pCCP1 and pCCP2 contain ~12
kb accessory modules that contain the same genes, but with different synteny. These
modules contain non-essential genes including a gene encoding for a putative DNA
relaxase/helicase, tetracycline resistance genes tetR/A, putative drug transporter gene
yedA, a hypothetical protein, Tn3 transposase, tnpR, and two additional transposase genes
(Figure 23). The accessory modules also display lower % GC than the mean ~ 57% GC
content of the entire genome, suggesting that the accessory modules was acquired by
horizontal gene transfer in recent evolutionary history.
We hypothesize that these two slightly different plasmids may have originated
from a single plasmid and diverged into two slightly different plasmids over the course of
this study. The original host (an unknown bacterium from stream sediment at Cooks
Creek Park) of this plasmid may have conjugated with multiple LA61 cells during the
exogenous plasmid capture, giving rise to the growth of two distinct transconjugant
colonies harboring identical tetR plasmids. After extracting each of the plasmids,
electrotransforming them into EC100, and maintaining the plasmids in separate EC100
cultures throughout this study, a transposon may have been horizontally transferred from
the chromosome of EC100 into the backbone of the original plasmid, but in different
ways between the two separate cultures. In pCCP1, the ~6 kb region from 26,600 –
32,581 bp aligns with 100% identity to a region of the EC100 genome containing the
genes tnpA (transposase), tnpR (resolvase), and tnpX (encodes a protein of unknown
function) which make up the Tn1000 transposon γδ (accession CP000948, E. coli str.
K12 substr. DH10B, complete genome) (Wang et al., 1994). In pCCP2, the ~6 kb region
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from 25,165 – 31,157 bp aligns with 99.99% identity to the same region of the EC100
chromosome.
We hypothesize that the Tn1000 transposon γδ was horizontally transferred from
EC100 into each of these identical tetR plasmids at slightly different locations within the
plasmids. Such artefacts caused by Tn1000 occur frequently in studies that use E. coli as
host strain for cloning experiments due to its lack of sequence specificity for insertion
(Broom et al., 1995). This would explain why the two plasmids appear to be slightly
different based on the restriction digest fragment patterns when each pCCP1 and pCCP2
were digested with EcoRI, SmaI, and HindIII (Supplementary Figure S19). Interestingly,
Tn1000 has been used to study the closest related plasmid of pCCP1 and pCCP2, IncP-9
plasmid pWW0 for purposes of transposon mutagenesis (Harayama et al., 1984). It is
also possible that these assembly differences were caused by shared regions of sequence
between the E. coli chromosome and the plasmids, however this would not explain the
differences observed in the in vitro and in silico restriction digest patterns. Long-range
PCR amplification of the accessory module regions of pCCP1 and pCCP2 followed by
Sanger sequencing of the PCR products may help differentiate the differences between
these nearly identical plasmids.
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Figure 24. Comparison of the (A) beginning and (B) end of pCCP1 genome to IncP-9
plasmid pWW0. Orange arrows represent CDS and they point in the direction of
transcription. CDS labeled as “hypo.” or without labels are “hypothetical proteins.”
Alignment percent identity is shown by the key’s in the bottom right corner, with darker
shades indicating a higher percent identity
pCCP1 and pCCP2 resistance phenotypes and genotypes. Plasmids pCCP1
and pCCP2 conferred resistance to tetracycline (Table 7). This phenotype is likely due to
the tetracycline resistance genes tetA/R that are located within accessory module 1 (AM1,
Figures 22 and S20). No other antibiotic resistance genes were identified within the
genomes, however a gene encoding a putative drug transporter yedA, which is known to
confer resistance to bromoacetate, was identified. It was not tested phenotypically.
Plasmis pCCP1 and pCCP2 also contain umuC/D (also known as ruvB/A) which confer
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resistance to UV light, These genes are typical to find on IncP-9 plasmids (Greated et al.,
2002). UV resistance genes may be part of a repair process for damaged DNA.
Potential origins of pCCP1 and pCCP2. The pCCP1 and pCCP2 genomes have
a mean % GC of 57.04 % and 57.09%, respectively. This is similar to the 57.8 % GC of
the backbone regions of the IncP-9 plasmid pWW0 (Greated et al., 2002). pWW0 was
originally isolated from Pseudomonas putida strain mt-2, whose genome has a % GC of
~60%. This suggests that pCCP1 and pCCP2 may have originated from a Pseudomonas
host. Plasmid pWW0 is a catabolic plasmid, with genes that code for the degradation and
utilization of xylenes and toluenes, and most, if not all, IncP-9 plasmids have originated
from Pseudomonas species and contain genes with catabolic functions (Dennis, 2005).
Plasmids pCCP1 and pCCP2 do not contain any obvious catabolic genes, suggesting that
any catabolic genes previously located on the genomes may have been lost in recent
evolutionary history.
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Conclusion
The pEG1-06, pCCRT11-6, pCCP1, and pCCP2 genomes demonstrate how genes
conferring resistance to antibiotics may have been acquired by recent incorporation of
integrons mobile genetic elements such as transposons or insertion sequences. Their
genomes have a modular organization of essential backbone functions such as plasmid
replication, maintenance and stability, partitioning, conjugative transfer as well as
accessory modules containing antibiotic resistance genes and genes of unknown
functions.
The ability of these four plasmids to be transferred into LA61 and the presence of
the various conjugative transfer genes (Tra, Dtr, and Mpf regions) suggests that these
plasmids are self-transmissible. The identification of the incompatibility groups of these
plasmids, IncP-1β, IncA/C2, and IncP-9 suggests that they are capable of horizontal
transfer via conjugation and replication in a broad host range of bacteria. These plasmids
have the potential to not only be transferred and replicated in a broad host range, but also
have the potential to be stable and difficult to be lost or cured from the host due to the
presence of the potential TA systems identified in each of the plasmids. Other factors also
contribute to the stability of these plasmids such as the potential high copy number of
pEG1-06.
Self-transmissible plasmids harboring multiple antibiotic resistance genes have
been characterized from environments such as wetlands downstream of wastewater
treatment plants (Botts et al., 2017), within waste water treatment plants (Schluter et al.,
2007), and livestock such as poultry (Rozwandowicz et al., 2018). Both IncA/C and IncP
plasmids are commonly found in clinical isolates and are associated with the worldwide
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spread of multi-drug resistance conferred by genes encoding extended-spectrum betalactamases, carbapenemases, and aminoglycoside resistance (Rozwandowicz et al.,
2018). IncP plasmids are known to be hosted by pathogenic Salmonella enterica
Typhimurium and E. coli and these plasmids carry genes that confer resistance to lastresort antibiotics such as colistin (Lu et al., 2016; Liu et al., 2017). Antibiotic resistance
among pathogenic bacteria is an urgent problem currently faced by public health
officials, and the problem is exacerbated by self-transmissible plasmids spreading among
nosocomial pathogens leading to nearly untreatable infections (San Milan, 2018).
Future studies are warranted to determine the minute differences between pCCP1
and pCCP2 genomes. Most of the fragments predicted by the in silico digests matched
fragments observed in the in vitro digests, however they could be futher verified by
visualization with a pulsed-field gel electrophoresis apparatus to view the larger
fragments (>10 kb) and a normal agarose gel with a shorter run time to view the smaller
fragments.
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Appendix
Supplemental Materials

Figure S1. ONT read length distribution for pEG1-06 replicate 1. Mean read length was
2,958.7 bases and median read length was 1,550 bases. The longest read for this sample
was 57,527 bases.
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Figure S2. ONT read length distribution for pEG1-06 replicate 2. Mean read length was
3,275.7 bases and median read length was 1,972 bases. The longest read for this sample
was 60,959 bases.

Figure S3. ONT read length distribution for pCCP1. Mean read length was 1,137 bases
and median read length was 914 bases. The longest read for this sample was 52,991
bases.
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Figure S4. ONT read length distribution for pCCP2. Mean read length was 1,130.3 bases
and median read length was 909 bases. The longest read for this sample was 37,146
bases.

Figure S5. ONT read length distribution for pCCRT11-6. Mean read length was 1,399.1
bases and median read length was 998 bases. The longest read for this sample was 49,965
bases.
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Figure S6. ONT read average Q score distribution for pEG1-06 replicate 1. Mean Q
score was 9.6 and median Q score was 9.8. The highest Q score for this sample was 12.4.

Figure S7. ONT read average Q score distribution for pEG1-06 replicate 2. Mean Q
score was 9.5 and median Q score was 9.7. The highest Q score for this sample was 12.2.
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Figure S8. ONT read average Q score distribution for pCCP1. Mean Q score was 9.6 and
median Q score was 9.8. The highest Q score for this sample was 12.5.

Figure S9. ONT read average Q score distribution for pCCP2. Mean Q score was 9.6 and
median Q score was 9.7. The highest Q score for this sample was 12.4.

Figure S10. ONT read average Q score distribution for pCCRT11-6. Mean Q score was
9.6 and median Q score was 9.8. The highest Q score for this sample was 12.6.
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Figure S11. Tablet screenshot pEG1-06 Illumina reads aligned against the pEG1-06
assembly using BWA, visualized using Tablet (Li, 2018; Milne et al., 2013).

Figure S12. Tablet screenshot of ONT reads aligned to pCCP2 assembly using
minimap2, visualized using Tablet (Li, 2018; Milne et al., 2013).
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Table S1. Complete list of pEG1-06 genes
Gene
strB
repA
Hypothetical protein
mazF
mazE
DNA primase
Hypothetical protein
ofxX
resolvase
Hypothetical protein
tetC
tetR
cytosine
methyltransferase
(IS200/IS605)
transposase (IS605)
Tn3 transposase
trfA
ssb
trbA (trfB_1)
ptlH (trbB)
trbC
trbD
virB4 (trbE)
trbF
virB9 (trbG)
trbH
virB10 (trbI)
trbJ
trbK
trbL
trbM
trbN
trbO
trbP

Start

Stop

Length
(bp)

Direction

559

1,188

630

R

1,244
1,767

1,738
2,093

495
327

R
R

2,090

2,413

324

R

2,413

2,637

225

R

2,704
3,143
3,421
4,804
5,375
5,559
6,842

3,138
3,424
4,173
5,109
5,503
6,749
7,477

435
282
753
306
129
1,191
636

R
F
F
R
F
R
F

DNA methylation

7,500

7,835

336

R

Transposase
Transposase
Plasmid replication
Plasmid replication
Mate pair formation
(Mpf)
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf
Mpf

8,098
9,514
11,357
12,624

9,411
10,734
12,577
12,965

1,314
1,221
1,221
342

F
F
R
R

13,079

13,441

363

F

13,751
14,730
15,198
15,506
18,061
18,861
19,763
20,256
21,677
22,451
22,689
24,425
25,026
25,690
25,956

14,713
15,194
15,509
18,064
18,843
19,760
20,251
21,656
22,441
22,678
24,407
25,012
25,661
25,956
26,654

963
465
312
2,559
783
900
489
1,401
765
228
1,719
588
636
267
699

F
F
F
F
F
F
F
F
F
F
F
F
F
F
F

Predicted function
Aminoglycoside
resistance
DNA Replication
Unknown
Toxin of
toxin/antitoxin (TA)
system
Antitoxin of TA
system
Unknown
Unknown
Unknown
Unknown
Unknown
Tetracycline resistance
Tetracycline resistance
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ompA
DNA methylase
xerD (intI)
Hypothetical protein
ant1_1 (ANT3)
emrE_1
folP_1 (sulI)
ydhC (floR)
tetR
tetG
gltC
tnpA (IS91)
groL
pse1 (CARB-3)
ant1_2 (ANT3)
emrE
folP_2 (sulI)
N-acetyltransferase
tniB
tnsB (tniA transposase)
traC
traD
topB (traE)
traF
traG
traI
traJ
traK
traL
traM
traN
traB (traO)
krfA
parB
parA

Mpf
DNA methylation
Integrase
Unknown
Aminoglycoside
resistance
Antiseptic resistance
Sulfonamide
resistance
Florfenicol resistance
Tetracycline resistance
Tetracycline resistance
Transcriptional
regulator
Transposase
Molecular chaperone
(protein folding)
Beta-lactam resistance
Aminoglycoside
resistance
Multi-drug efflux
pump
Sulfonamide
resistance
Aminoglycoside
resistance
Transposase
Transposase
DNA Transfer (Dtr)
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Dtr
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability

26,670
27,256
28,177
29,342

27,101
27,930
29,190
29,575

432
675
1,014
234

F
F
R
F

29,648

30,487

840

F

30,651

30,998

348

F

30,992

31,963

972

F

32,180
33,601
34,331

33,394
34,227
35,506

1,215
627
1,176

F
R
F

35,596

36,318

723

F

36,410

37,942

1,533

R

38,169

38,822

654

R

38,980

39,894

915

F

39,994

40,803

810

F

40,967

41,314

348

F

41,308

42,147

840

F

42,275

42,775

501

F

42,744
43,739
45,969
50,319
50,730
52,805
53,338
55,248
57,523
58,271
58,669
59,394
60,037
60,719

43,736
45,418
50,315
50,708
52,793
53,341
55,251
57,488
57,897
58,669
59,394
59,834
60,690
61,066

993
1,680
4,347
390
2,064
537
1,914
2,241
375
399
726
441
654
348

R
R
R
R
R
R
R
R
R
F
F
F
R
R

61,237

62,268

1,032

R

62,448

63,497

1,050

R

63,494

64,258

765

R
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trfB (KorA)
kleF
kleE
kleB
kleA

korC

klcB
klcA
nikR (type II TA
system ParD family
antitoxin)
relE/ParE family toxin
Hypothetical protein
Hypothetical protein
Hypothetical protein

Plasmid
maintenance/Stability
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability,
transcriptional
regulator
Plasmid
maintenance/Stability
Plasmid
maintenance/Stability

64,255

64,566

312

R

64,671

65,201

531

R

65,203

65,532

330

R

65,677

65,892

216

R

65,951

66,187

237

R

66,347

66,604

258

R

66,621

67,826

1,206

R

67,878

68,306

429

R

Antitoxin of TA
system

68,475

68,744

270

F

Toxin of TA system
Unknown
Unknown
Unknown

68,741
70,282
70,975
71,221

69,055
70,704
71,205
71,361

315
423
231
141

F
R
R
R

Table S2. Complete list of pCCRT11-6 genes
Gene

Predicted Function

Start

Stop

repA
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein

Plasmid replication
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Disulfide bond
formation protein
(protein folding
stabilization)
Unknown
Unknown
Unknown
ATP-dependent zinc

37
2,333
3,020
3,674
4,287
4,811
5,429
5,913
6,211

1,107
2,767
3,172
4,282
4,808
5,332
5,902
6,206
7,098

Length
(bp)
1,071
435
153
609
522
522
474
294
888

7,114

7,971

858

F

8,035
8,538
8,752
10,071

8,526
8,765
9,609
11,534

492
228
858
1,464

F
F
F
F

dsbA
hypothetical protein
hypothetical protein
hypothetical protein
ftsH3

Direction
F
R
R
F
F
F
F
F
F
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hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
noc
hypothetical protein
hypothetical protein
parA
parB
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
yedA

tetA
tetR
relaxase/helicase
hypothetical protein
hypothetical protein
IS26 family
transposase
hypothetical protein
bin3
hypothetical protein
tnpA (IS91 family
transposase)
hypothetical protein
bcr (FloR)

cynR

metalloprotease
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Nucleoid occlusion
protein
Unknown
Unknown
Plasmid partitioning
Plasmid partitioning
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Multi-drug
resistance (putative
inner membrane
transporter)
Tetracycline
resistance
Tetracycline
resistance
Transposase
Unknown
Unknown

11,609
11,943
12,384
12,572
13,729
14,073

11,938
12,335
12,581
13,717
14,076
14,180

330
393
198
1,146
348
108

F
F
F
F
F
F

14,210

15,142

933

F

15,142
15,416
16,570
17,359
18,574
18,899
19,613
20,192
20,495
21,738

15,321
16,306
17,355
18,525
18,846
19,468
20,188
20,461
20,776
21,857

180
891
786
1,167
273
570
576
270
282
120

F
F
F
F
F
R
F
F
F
R

21,994

22,692

699

F

22,724

23,923

1,200

R

24,002

24,664

663

F

24,696
25,086
25,665

24,938
25,661
25,841

243
576
177

R
F
F

Transposase

25,853

26,557

705

F

Unknown
Putative transposon
Tn552 DNAinvertase (resolvase)
Unknown

26,591

27,082

492

R

27,189

27,926

738

F

27,923

28,147

225

F

transposase

28,358

29,851

1,494

F

Unknown
Bicyclomycin/chlora
mphenicol/florfenic
ol resistance
HTH-type
transcriptional
regulator

30,149

30,604

456

R

30,983

32,197

1,215

F

32,225

32,530

306

F

110
IS91 family
transposase
strB
Aer
hypothetical protein
topB
hypothetical protein
hypothetical protein
traI
traD
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
traL
traE
traK
traB
traV
traA
hypothetical protein
dsbC
traC
hypothetical protein
trhF
traW
pdeR
traU
traN
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
cobS

transposase
Aminoglycoside
resistance
Aerotaxis receptor
Unknown
DNA topoisomerase
3, conjugative
transfer
Unknown
Unknown
conjugative transfer
(Tra)
Tra
Unknown
Unknown
Unknown
Unknown
Unknown
Tra
Tra
Tra
Tra
Tra
Tra
Unknown
Protein folding
Tra
Unknown
Conjugative transfer
signal peptidase
Dtr
Cyclic di-GMP
phosphodiesterase
Dtr
Dtr
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Aerobic
cobaltochelatase
subunit

32,642

33,181

540

F

33,153

33,989

837

R

34,364
36,796

36,472
36,939

2,109
144

F
R

37,327

39,516

2,190

R

39,540
39,731

39,749
40,348

210
618

R
R

40,516

43,491

2,976

F

43,488
45,403
45,905
46,819
47,547
47,687
48,169
48,450
49,057
49,971
51,284
51,869
52,442
58,076
58,780
61,242

45,353
45,948
46,534
47,196
47,690
47,998
48,450
49,073
49,974
51,287
51,856
52,252
57,928
58,783
61,227
61,559

1,866
546
630
378
144
312
282
624
918
1,317
573
384
5,487
708
2,448
318

F
F
F
F
F
R
F
F
F
F
F
F
F
F
F
F

61,556

62,086

531

F

62,049

63,314

1,266

F

63,311

63,982

672

F

63,979
65,102
67,991
68,973
69,680
69,921
70,336
70,477

64,986
67,903
68,851
69,623
69,910
70,241
70,428
70,707

1,008
2,802
861
651
231
321
93
231

F
F
R
R
F
F
F
F

70,947

71,915

969

F

111
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hhaIM
hypothetical protein
hypothetical protein
phosphoadenosine
phosphosulfate
reductase
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
DNA primase
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
IS4 transposase
VapC50
DNA binding protein
hypothetical protein
hypothetical protein
xerD
hypothetical protein

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Modification
methylase HhaI
Unknown
Unknown

71,926
72,956
73,982
75,191
76,541
78,368
78,922
79,247
79,366
79,574
80,063
80,443
80,776
81,036
81,583
82,004

72,831
73,921
74,992
76,456
78,253
78,856
79,254
79,369
79,503
79,927
80,431
80,718
80,967
81,389
81,927
82,306

906
966
1,011
1,266
1,713
489
333
123
138
354
369
276
192
354
345
303

F
F
F
F
F
F
F
R
R
F
F
F
F
F
F
F

82,384

83,772

1,389

F

83,833
84,337

84,264
84,891

432
555

F
F

Sulfur metabolism

85,121

87,571

2,451

F

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
transposase
Putative
ribonuclease (toxin)
of TA system
Unknown
Unknown
Unknown
Tyrosine
recombinase
(integrase)
Unknown

87,773
88,018
88,312
89,312
89,876
91,608
91,960
92,205
92,798
93,703
97,604

88,021
88,230
89,109
89,698
91,621
91,868
92,208
92,324
93,523
97,461
98,491

249
213
798
387
1,746
261
249
120
726
3,759
888

F
F
F
F
F
F
F
F
F
F
R

98,961

99,536

576

R

99,536
99,994
100,233

99,997
100,233
100,445

462
240
213

R
R
R

100,474

101,472

999

F

101,529

102,023

495

F

112
hypothetical protein
tus
hypothetical protein
hypothetical protein
hns
addA
traF
traH
traG
permease
ner

transglycosylase
hypothetical protein
flhC
hypothetical protein
DNA binding protein
hypothetical protein
stbA
hypothetical protein

Unknown
DNA replication
terminus sitebinding protein
Unknown
Unknown
DNA-binding
protein
ATP-dependent
helicase/nuclease
subunit A
Tra
Tra
Tra
Unknown
Nucleotide excision
repair protein
Soluble lytic murein
transglycosylase and
related regulatory
protein
Unknown
Flagellar
transcriptional
regulator
Unknown
Unknown
Unknown
Plasmid stability
Unknown

102,116

102,910

795

R

103,667

104,542

876

F

104,555
105,341

105,340
105,487

786
147

R
R

105,599

106,024

426

R

106,379

107,890

1,512

F

108,013
109,043
110,489
114,128

109,041
110,476
114,091
114,490

1,029
1,434
3,603
363

F
F
F
R

115,195

115,467

273

F

115,467

116,000

534

F

116,009

116,617

609

F

116,614

117,165

552

F

117,472
118,452
118,873
119,183
120,567

118,245
118,871
119,166
120,166
121,193

774
420
294
984
627

F
R
R
R
F

Start

Stop

1
580
1,260
1,543
2,229
3,502

555
1,242
1,550
2,088
3,500
4,242

Length
(bp)
555
663
291
546
1,272
741

4,263

5,549

1,287

R

5,539

5,970

432

R

Table S3. Complete list of pCCP1 genes
gene
replication protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
umuC
umuD

Predicted
Function
DNA replication
Unknown
Unknown
Unknown
Unknown
Unknown
Y-family DNA
polymerase
UV resistance
protein

Direction
F
F
F
F
F
F
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ligD
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative addiction
module antidote
protein
type II toxin-antitoxin
system RelE/ParE
family toxin
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
DNA cytosine
methyltransferase
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
ssb
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
relaxase/helicase
tetR

tetA

yedA
Tn3 family
transposase
Tn3 family

Multifunctional
non-homologous
end joining protein
Unknown
Unknown
Unknown
Unknown

6,109

7,062

954

F

7,073
8,476
8,795
9,029

7,366
8,793
9,016
9,352

294
318
222
324

F
R
R
R

Antitoxin of TA
system

9,375

9,674

300

R

Toxin of TA system

9,671

9,973

303

R

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown

10,177
11,110
11,478
11,885
12,164
12,512
13,750

10,956
11,478
11,828
12,103
12,445
13,603
13,992

780
369
351
219
282
1,092
243

F
F
F
F
F
F
F

DNA methylation

14,044

15,726

1,683

F

Unknown
Unknown
Unknown
Unknown
Single-stranded
DNA-binding
protein
Unknown
Unknown
Unknown
Unknown
Unknown
Tetracycline
repressor protein
class A from
transposon 1721
Tetracycline
resistance protein,
class C
putative inner
membrane
transporter

15,820
16,045
16,493
17,418

16,041
16,485
16,759
17,807

222
441
267
390

F
F
F
F

17,832

18,365

534

F

18,584
19,470
19,918
20,252
20,742

19,411
19,901
20,232
20,686
21,545

828
432
315
435
804

F
F
F
F
F

21,577

22,254

678

R

22,258

23,532

1,275

F

23,564

24,448

885

R

Transposase

24,937

26,637

1,701

F

Transposase

26,634

29,642

3,009

R

114
transposase
tnpR
transposase
hypothetical protein
zinc metalloprotease
hypothetical protein
stdB
traD
hypothetical protein
traD (or trwB)
traI
hypothetical protein
hypothetical protein
nuclease
pld
hypothetical protein
virB1
virB11
virB10
virB9
virB8
type VI secretion
protein
hypothetical protein
hypothetical protein
virB5
virB4
virB3
virB2
Hypothetical protein
parA
parB
parR
hypothetical protein

Transposon
gamma-delta
resolvase
Transposase
Unknown
Unknown
Unknown
hypothetical protein
Dtr
Unknown
Dtr
Dtr
Unknown
Unknown
Unknown
Phospholipase D
(endonuclease)
Unknown
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type VI secretion
protein
Unknown
Unknown
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Unknown
Plasmids
partitioning
Plasmid partitioning
Plasmid partitioning
Unknown

29,806

30,357

552

F

30,373
33,248
33,849
34,777
35,173
35,889
36,776
37,159
38,721
41,710
42,551
43,120

32,469
33,730
34,646
35,169
35,892
36,344
37,159
38,709
41,657
42,579
43,108
43,755

2,097
483
798
393
720
456
384
1,551
2,937
870
558
636

F
R
R
R
R
R
F
F
F
F
R
R

43,768

44,319

552

R

44,363

44,698

336

R

44,727

45,644

918

R

45,628

46,656

1,029

R

46,666

47,928

1,263

R

47,931

48,716

786

R

48,744

49,418

675

R

49,418

50,281

864

R

50,269
50,654

50,661
50,866

393
213

R
R

50,895

51,587

693

R

51,584

54,184

2,601

R

54,255

54,551

297

R

54,560

55,021

462

R

55,038

55,310

273

R

56,024

56,791

768

F

56,802
57,740
58,087

57,743
58,090
58,494

942
351
408

F
F
F
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bin3 (resolvase)

Putative transposon
Tn552 DNAinvertase
(resolvase)

58,751

59,386

636

F

Table S4. Complete list of pCCP2 genes
Gene

Product

Start

Stop

replication protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
umuC
umuD

Plasmid replication
Unknown
Unknown
Unknown
Unknown
Unknown
Protein UmuC
Protein UmuD
Multifunctional
non-homologous
end joining protein
LigD
Unknown
Unknown
Unknown
Unknown

1
580
1,260
1,543
2,229
3,502
4,263
5,539

555
1,242
1,550
2,088
3,500
4,242
5,549
5,970

Length
(bp)
555
663
291
546
1,272
741
1,287
432

6,109

7,062

954

F

7,073
8,476
8,795
9,029

7,366
8,793
9,016
9,352

294
318
222
324

F
R
R
R

Antitoxin of TA
system

9,375

9,674

300

R

Toxin of TA
system

9,671

9,973

303

R

Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown

10,177
11,110
11,478
11,885
12,164
12,512
13,750

10,956
11,478
11,828
12,103
12,445
13,603
13,992

780
369
351
219
282
1,092
243

F
F
F
F
F
F
F

Methylation

14,044

15,726

1,683

F

Unknown
Unknown
Unknown
Unknown

15,820
16,045
16,493
17,418

16,041
16,485
16,759
17,807

222
441
267
390

F
F
F
F

ligD
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
putative addiction
module antidote
protein
type II toxin-antitoxin
system RelE/ParE
family toxin
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
DNA cytosine
methyltransferase
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein

Direction
F
F
F
F
F
F
R
R

116

ssb
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
relaxase/helicase
tetR

tetA

yedA
hypothetical protein
Tn3 family
transposase
tnpR
transposase
Tn3-like element
TnAs1 family
transposase
hypothetical protein
zinc metalloprotease
hypothetical protein
stdB
traD
hypothetical protein
traD (or trwB)
traI
hypothetical protein
hypothetical protein
nuclease
pld
hypothetical protein
virB1
virB11
virB10

Single-stranded
DNA-binding
protein
Unknown
Unknown
Unknown
Unknown
Unknown
Tetracycline
repressor protein
class A from
transposon 1721
Tetracycline
resistance protein,
class C
putative inner
membrane
transporter YedA
Unknown

17,832

18,365

534

F

18,584
19,470
19,918
20,252
20,742

19,411
19,901
20,232
20,686
21,545

828
432
315
435
804

F
F
F
F
F

21,577

22,254

678

R

22,258

23,532

1,275

F

23,564

24,448

885

R

24,937

25,203

267

F

25,200

28,208

3,009

R

28,372

28,923

552

F

28,939

31,035

2,097

F

Transposase

31,310

32,719

1,410

F

Unknown
Unknown
Unknown
Plasmid stability
DNA Transfer
(Dtr)
Unknown
Dtr
Dtr
Unknown
Unknown
Unknown
Phospholipase D
Unknown
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion

33,248
33,849
34,777
35,173

33,730
34,646
35,169
35,892

483
798
393
720

R
R
R
R

35,889

36,344

456

R

36,776
37,159
38,721
41,710
42,551
43,120
43,768
44,363

37,159
38,709
41,657
42,579
43,108
43,755
44,319
44,698

384
1,551
2,937
870
558
636
552
336

F
F
F
F
R
R
R
R

44,727

45,644

918

R

45,628

46,656

1,029

R

46,666

47,928

1,263

R

Transposase
Transposon
gamma-delta
resolvase
Transposase

117

virB9
virB8
type VI secretion
protein
hypothetical protein
hypothetical protein
virB5
virB4
virB3
virB2
hypothetical protein
parA
parB
parR
hypothetical protein
bin3

system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type VI secretion
system protein
Unknown
Unknown
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Type IV secretion
system protein
Unknown
Plasmid
partitioning
Plasmid
partitioning
Plasmid
partitioning
Unknown
Putative transposon
Tn552 DNAinvertase
(resolvase)

47,931

48,716

786

R

48,744

49,418

675

R

49,418

50,281

864

R

50,269
50,654

50,661
50,866

393
213

R
R

50,895

51,587

693

R

51,584

54,184

2,601

R

54,255

54,551

297

R

54,560

55,021

462

R

55,038

55,310

273

R

56,024

56,791

768

F

56,802

57,743

942

F

57,740

58,090

351

F

58,087

58,494

408

F

58,751

59,386

636

F

Table S5. In silico digest predictions and observations of pEG1-06 digested with EcoRI
Fragment number Fragment Size (bp)
Seen on gel image?
Yes, but bands
25,817
F4
overlap
Yes, but bands
21,623
F2
overlap
12,010
Yes
F1
8,331
Yes
F6
2,772
Yes
F3
863
Yes
F5
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Figure S13. Restriction digestion of pEG1-06 with EcoRI. Left lane: pEG1-06 digested
by EcoRI, right lane: lambda/HindIII molecular weight standard. Red line indicates
where the image was cut to remove unnecessary lanes.

Table S6. In silico digest predictions and observations of pEG1-06 digested with HindIII
Fragment number Fragment Size (bp)
Seen on gel image?
Yes, but bands
28,830
F8
overlap
Yes, but bands
19,889
F2
overlap
9,286
Yes
F4
8,177
Yes
F9
4,045
Yes
F1
717
No
F5
159
No
F7
159
No
F3
154
No
F6
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Figure S14. Restriction digestion of pEG1-06 with EcoRI and HindIII. Lane L:
lambda/HindIII digest, lane 2: pEG1-06, lane 3: pEG1-06 digested with EcoRI, lane 4:
pEG1-06 digested with HindIII.

Table S7. In silico digest predictions and observations of pEG1-06 digested with SmaI
Fragment number Fragment Size (bp)
Seen on gel image?
43,580
Yes
F3
17,130
Yes
F2
10,706
Yes
F1
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Figure S15. Restriction digestion of pEG1-06 with EcoRI and SmaI. Lane L:
lambda/HindIII digest, lane 2: pEG1-06, lane 3: pEG1-06 digested with EcoRI, lane 4:
pEG1-06 digested with SmaI.

Table S8. In silico digest predictions and observations of pCCRT11-6 digested with
EcoRI
Fragment number Fragment Size (bp) Seen on gel image?
51,264
Yes
F8
43,712
Yes
F3
11,669
Yes
F2
5,473
Yes
F1
4,628
Yes
F4
3,839
Yes
F7
600
No
F5
284
No
F6
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Figure S16. Restriction digestion of pCCRT11-6 with EcoRI. Lane 1: pCCRT11-6, lane
2: pCCRT11-6 digested with EcoRI, lane L: lambda/HindIII digest.
Table S9. In silico digest predictions and observations of pCCRT11-6 digested with
HindIII
Fragment number Fragment Size (bp) Seen on gel image?
121,469
Yes
F1
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Figure S17. Restriction digestion of pCCRT11-6 with HindIII. Lane 1: pCCRT11-6
digested with HindIII, lane L: lambda/HindIII digest. Red line indicates where the image
was cut to remove unnecessary lanes.

Table S10. In silico digest predictions and observations of pCCRT11-6 digested with
SmaI
Fragment number Fragment Size (bp) Seen on gel image?
104,834
Yes
F3
15,869
Yes
F1
766
No
F2
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Figure S18. Restriction digestion of pCCRT11-6 with EcoRI and SmaI. Lane L:
lambda/HindIII, lane 1: pCCRT11-6, lane 2: pCCRT11-6 digested with EcoRI, lane 3:
pCCRT11-6 digested with SmaI. Red line indicates where the image was cut to remove
unnecessary lanes.

Table S11. In silico digest predictions and observations of pCCP1 digested with HindIII
Fragment number Fragment Size (bp) Seen on gel image?
22,980
Yes
F6
13,827
Yes
F3
11,659
Yes
F4
7,528
Yes
F1
2,561
Yes
F2
1,287
Yes
F5
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Figure S19. Restriction digestion of pCCP1 and pCCP2 with EcoRI, HindIII and SmaI.
Lanes L: lambda/HindIII digest, lane 1: pCCP1 digested with EcoRI, lane 2: pCCP2
digested with EcoRI, lane 3: pCCP1 digested with HindIII, lane 4: pCCP2 digested with
HindIII, lane 5: pCCP1 digested with SmaI, lane 6: pCCP2 digested with SmaI, lane 7:
pCCP1 digested with EcoRI and PS treated, lane 8: pCCP1 digested with EcoRI (PS
treated and Agencourt cleaned). Gel image was cut between the first ladder lane and lane
1 to remove unnecessary lanes.
Table S12. In silico digest predictions and observations of pCCP1 digested with SmaI
Fragment number Fragment Size (bp) Seen on gel image?
7,963
Yes, bands overlap
F3
7,490
Yes, bands overlap
F15
6,718
Yes
F10
5,525
Yes, bands overlap
F9
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F2
F14
F16
F5
F11
F7
F13
F12
F1
F8
F6
F4

5,406
4,591
4,166
3,631
3,505
3,458
2,997
1,989
1,524
766
70
40

Yes, bands overlap
Yes
Yes
Yes, bands overlap
Yes, bands overlap
Yes, bands overlap
Yes
Yes
Yes
No
No
No

Table S13. In silico digest predictions and observations of pCCP2 digested with EcoRI
Fragment number Fragment Size (bp) Seen on gel image?
14,139
Yes
F8
9,056
Yes
F3
8,142
Yes
F5
6,256
Yes
F2
4,952
Yes
F4
4,293
Yes, bands overlap
F11
4,240
Yes, bands overlap
F10
2,523
Yes
F7
2,378
Yes
F9
1,344
No
F14
845
No
F6
686
No
F12
619
No
F13
369
No
F1
Table S14. In silico digest predictions and observations of pCCP2 digested with HindIII
Fragment number Fragment Size (bp) Seen on gel image?
22,980
Yes
F6
15,261
Yes
F3
11,659
Yes
F4
6,094
Yes
F1
2,561
Yes
F2
1,287
Yes
F5
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Table S15. In silico digest predictions and observations of pCCP2 digested with SmaI
Fragment number Fragment Size (bp) Seen on gel image?
Yes, bands overlap
F10
8,152
Yes, bands overlap
F3
7,963
Yes
F15
7,490
Yes
F2
5,406
Yes
F14
4,591
Yes, bands overlap
F16
4,166
(with F9)
Yes, bands overlap
F9
4,091
(with F16)
Yes, bands overlap
F5
3,631
(with F11 and F7)
Yes, bands overlap
F11
3,505
(with F5 and F7)
Yes, bands overlap
F7
3,458
(with F5 and F11)
Yes
F13
2,997
Yes
F12
1,989
Yes
F1
1,524
No
F8
766
No
F6
70
No
F4
43
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Figure S20. Functional modules and CDS mapped to the pCCP1 genome assembly.
Coding sequences and annotations are on the outer circle (outermost CDS are on
complementary strand and the inner CDS are on the template strand): CDS annotated by
Prokka and confirmed by BLASTp search (gold), antibiotic resistance genes annotated
with ABRicate (red), and CDS annotated by Prokka as “hypothetical protein” (grey).
Plasmid functional modules labeled on the inner circle: Accessory Module (AM1) (red),
stability and partitioning regions (orange), DNA transfer (Dtr) and mate pair formation
(Mpf) regions (blue), and replication regions (yellow). Inner blue trace represents % GC.
pCCP2 has a 57.09 % mean GC content.
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